Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-324-5p GLI1 0.05 0.8165 -0.23 0.34765 mir2Disease; miRNAWalker2 validate; miRTarBase -0.44 0
2 hsa-miR-326 GLI1 0.17 0.33213 -0.23 0.34765 mir2Disease; miRNAWalker2 validate; miRTarBase -0.23 0.00077
3 hsa-let-7a-3p BTF3 -0.21 0.43957 -0.03 0.94181 miRNAWalker2 validate -0.15 0
4 hsa-let-7a-3p SENP7 -0.21 0.43957 0.11 0.62508 miRNAWalker2 validate -0.2 2.0E-5
5 hsa-let-7a-5p ACVR1B -0.3 0.66786 0.2 0.45588 miRNAWalker2 validate; TargetScan; miRNATAP -0.2 2.0E-5
6 hsa-let-7a-5p ANO6 -0.3 0.66786 0.09 0.7632 miRNAWalker2 validate -0.15 0.01322
7 hsa-let-7a-5p C1GALT1 -0.3 0.66786 0.15 0.42899 miRNAWalker2 validate; TargetScan -0.23 0.00062
8 hsa-let-7a-5p C2CD4A -0.3 0.66786 -0.16 0.61922 miRNAWalker2 validate -0.45 0.0305
9 hsa-let-7a-5p CAND2 -0.3 0.66786 0.31 0.15774 miRNAWalker2 validate -0.23 0.02834
10 hsa-let-7a-5p CDC25B -0.3 0.66786 0.45 0.13718 miRNAWalker2 validate -0.4 0
11 hsa-let-7a-5p CDC7 -0.3 0.66786 0.48 0.00911 miRNAWalker2 validate -0.22 0.0133
12 hsa-let-7a-5p CDK6 -0.3 0.66786 0.48 0.05659 miRNAWalker2 validate; miRTarBase; TargetScan -0.58 0
13 hsa-let-7a-5p CRYBG3 -0.3 0.66786 -0.07 0.76745 miRNAWalker2 validate -0.26 0.02082
14 hsa-let-7a-5p DNAJC6 -0.3 0.66786 0.81 4.0E-5 miRNAWalker2 validate -0.43 0.00082
15 hsa-let-7a-5p E2F1 -0.3 0.66786 0.51 0.02166 miRNAWalker2 validate -0.25 0.01437
16 hsa-let-7a-5p HDAC5 -0.3 0.66786 0.08 0.79216 miRNAWalker2 validate -0.12 0.02451
17 hsa-let-7a-5p HMGA1 -0.3 0.66786 0.47 0.16754 miRNAWalker2 validate; miRTarBase; MirTarget; TargetScan; miRNATAP -0.53 0
18 hsa-let-7a-5p HMGA2 -0.3 0.66786 1.05 0.00089 miRNAWalker2 validate; miRTarBase; MirTarget; TargetScan -0.79 9.0E-5
19 hsa-let-7a-5p HOXA6 -0.3 0.66786 0.35 0.20214 miRNAWalker2 validate -0.7 8.0E-5
20 hsa-let-7a-5p IGF2 -0.3 0.66786 0.74 0.11066 miRNAWalker2 validate; miRTarBase -0.75 0.00012
21 hsa-let-7a-5p ITGB3 -0.3 0.66786 0.56 0.03181 miRNAWalker2 validate; miRTarBase; MirTarget; TargetScan; miRNATAP -0.85 0
22 hsa-let-7a-5p ITM2B -0.3 0.66786 0.04 0.93566 miRNAWalker2 validate -0.13 0.026
23 hsa-let-7a-5p JPH4 -0.3 0.66786 0.17 0.51199 miRNAWalker2 validate -0.33 0.04331
24 hsa-let-7a-5p KCTD1 -0.3 0.66786 0.15 0.59122 miRNAWalker2 validate -0.15 0.04807
25 hsa-let-7a-5p LHFPL2 -0.3 0.66786 -0.03 0.89888 miRNAWalker2 validate -0.13 0.03325
26 hsa-let-7a-5p LIN28A -0.3 0.66786 0.14 0.68294 miRNAWalker2 validate; TargetScan; miRNATAP -0.67 0.00014
27 hsa-let-7a-5p MIB1 -0.3 0.66786 0.11 0.6976 miRNAWalker2 validate; MirTarget; TargetScan; miRNATAP -0.13 0.01495
28 hsa-let-7a-5p MRPL15 -0.3 0.66786 0.28 0.28663 miRNAWalker2 validate -0.17 0.00051
29 hsa-let-7a-5p MYC -0.3 0.66786 0.22 0.47236 miRNAWalker2 validate; miRTarBase -0.24 0.01455
30 hsa-let-7a-5p NID2 -0.3 0.66786 0.31 0.17273 miRNAWalker2 validate; TargetScan; miRNATAP -0.36 0.0003
31 hsa-let-7a-5p NKIRAS2 -0.3 0.66786 0.03 0.92249 miRNAWalker2 validate; miRTarBase; TargetScan; miRNATAP -0.11 0.0016
32 hsa-let-7a-5p NRAS -0.3 0.66786 0.35 0.2078 miRNAWalker2 validate; miRTarBase; MirTarget; TargetScan; miRNATAP -0.18 0.0021
33 hsa-let-7a-5p NUDT5 -0.3 0.66786 0.08 0.75433 miRNAWalker2 validate -0.14 0.00609
34 hsa-let-7a-5p QKI -0.3 0.66786 0.25 0.39568 miRNAWalker2 validate -0.19 0.0009
35 hsa-let-7a-5p SNRPC -0.3 0.66786 0.18 0.5412 miRNAWalker2 validate -0.13 0.00275
36 hsa-let-7a-5p TARS -0.3 0.66786 0.16 0.59869 miRNAWalker2 validate -0.12 0.01734
37 hsa-let-7b-5p ACPP -0.32 0.62665 0.2 0.23372 miRNAWalker2 validate -0.16 0.04252
38 hsa-let-7b-5p ADRM1 -0.32 0.62665 0.2 0.53958 miRNAWalker2 validate -0.14 7.0E-5
39 hsa-let-7b-5p ALG3 -0.32 0.62665 0.18 0.51509 miRNAWalker2 validate -0.15 0.00018
40 hsa-let-7b-5p ARID3A -0.32 0.62665 0.06 0.71256 miRNAWalker2 validate -0.28 1.0E-5
41 hsa-let-7b-5p ASNA1 -0.32 0.62665 0.02 0.9559 miRNAWalker2 validate -0.06 0.0362
42 hsa-let-7b-5p ATG4B -0.32 0.62665 -0.01 0.98353 miRNAWalker2 validate; miRNATAP -0.07 0.02869
43 hsa-let-7b-5p ATP1A1 -0.32 0.62665 0.08 0.8582 miRNAWalker2 validate -0.08 0.03014
44 hsa-let-7b-5p ATP6V1F -0.32 0.62665 0.08 0.79812 miRNAWalker2 validate -0.06 0.04148
45 hsa-let-7b-5p AURKA -0.32 0.62665 0.54 0.00725 miRNAWalker2 validate -0.24 0.00081
46 hsa-let-7b-5p BIRC5 -0.32 0.62665 0.5 0.03233 miRNAWalker2 validate -0.21 0.03353
47 hsa-let-7b-5p BMP7 -0.32 0.62665 1.24 0.00032 miRNAWalker2 validate -0.76 0
48 hsa-let-7b-5p BZW2 -0.32 0.62665 0.16 0.56767 miRNAWalker2 validate; MirTarget; miRNATAP -0.14 0.00028
49 hsa-let-7b-5p C1GALT1 -0.32 0.62665 0.15 0.42899 miRNAWalker2 validate -0.14 0.00325
50 hsa-let-7b-5p CAPG -0.32 0.62665 0.2 0.52136 miRNAWalker2 validate -0.27 0
51 hsa-let-7b-5p CBX6 -0.32 0.62665 0.41 0.10738 miRNAWalker2 validate -0.15 0.04
52 hsa-let-7b-5p CCNJ -0.32 0.62665 -0.02 0.9174 miRNAWalker2 validate; MirTarget; miRNATAP -0.1 0.01051
53 hsa-let-7b-5p CDC25A -0.32 0.62665 0.28 0.11229 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.21 0.00161
54 hsa-let-7b-5p CDCA8 -0.32 0.62665 0.36 0.08727 miRNAWalker2 validate -0.18 0.01738
55 hsa-let-7b-5p CDK6 -0.32 0.62665 0.48 0.05659 miRNAWalker2 validate; miRTarBase -0.37 0
56 hsa-let-7b-5p CENPV -0.32 0.62665 0.51 0.02578 miRNAWalker2 validate -0.41 0
57 hsa-let-7b-5p CHD7 -0.32 0.62665 0.06 0.79195 miRNAWalker2 validate -0.15 0.00118
58 hsa-let-7b-5p CKS2 -0.32 0.62665 0.13 0.5854 miRNAWalker2 validate -0.13 0.03618
59 hsa-let-7b-5p COX7B -0.32 0.62665 0.03 0.91005 miRNAWalker2 validate -0.08 0.03277
60 hsa-let-7b-5p DPYSL5 -0.32 0.62665 1.44 6.0E-5 miRNAWalker2 validate -0.75 0
61 hsa-let-7b-5p DZIP1 -0.32 0.62665 0.22 0.41585 miRNAWalker2 validate; miRNATAP -0.24 0.00325
62 hsa-let-7b-5p E2F3 -0.32 0.62665 0.32 0.13825 miRNAWalker2 validate -0.11 0.00485
63 hsa-let-7b-5p E2F5 -0.32 0.62665 0.21 0.26997 miRNAWalker2 validate; MirTarget; miRNATAP -0.24 3.0E-5
64 hsa-let-7b-5p EEF1E1 -0.32 0.62665 0.16 0.43582 miRNAWalker2 validate -0.15 1.0E-5
65 hsa-let-7b-5p FAM105A -0.32 0.62665 0.18 0.28778 miRNAWalker2 validate -0.14 0.02081
66 hsa-let-7b-5p FAM49B -0.32 0.62665 0.37 0.13144 miRNAWalker2 validate -0.19 4.0E-5
67 hsa-let-7b-5p FLNA -0.32 0.62665 0.3 0.53968 miRNAWalker2 validate -0.16 0.01116
68 hsa-let-7b-5p GATC -0.32 0.62665 0.03 0.80244 miRNAWalker2 validate -0.15 0.00479
69 hsa-let-7b-5p GDF11 -0.32 0.62665 -0.17 0.48439 miRNAWalker2 validate -0.16 0.00294
70 hsa-let-7b-5p GEMIN7 -0.32 0.62665 0.11 0.56815 miRNAWalker2 validate -0.12 0.00042
71 hsa-let-7b-5p GPI -0.32 0.62665 0.21 0.60215 miRNAWalker2 validate -0.11 0.0102
72 hsa-let-7b-5p GTPBP3 -0.32 0.62665 0.2 0.35802 miRNAWalker2 validate -0.08 0.02099
73 hsa-let-7b-5p HELLS -0.32 0.62665 0.26 0.12706 miRNAWalker2 validate -0.12 0.03473
74 hsa-let-7b-5p HMGA1 -0.32 0.62665 0.47 0.16754 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.43 0 23798998 Furthermore we identified HMGA1 a non-histone protein as a new target of let-7b and found correlation of let-7b down-regulation with HMGA1 over-expression in primary PCa samples
75 hsa-let-7b-5p HMGA2 -0.32 0.62665 1.05 0.00089 miRNAWalker2 validate; miRTarBase; MirTarget -0.59 5.0E-5 18413822 The expressions of let-7a let-7b and let-7c in gastric cancer patients with low HMGA2 expression were significantly higher than those with high HMGA2 expression P < 0.05
76 hsa-let-7b-5p IGF2BP1 -0.32 0.62665 2.12 0 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -1.01 0
77 hsa-let-7b-5p IGF2BP2 -0.32 0.62665 1.37 8.0E-5 miRNAWalker2 validate; MirTarget; miRNATAP -0.98 0
78 hsa-let-7b-5p IGF2BP3 -0.32 0.62665 1.31 0 miRNAWalker2 validate; MirTarget -0.65 0
79 hsa-let-7b-5p IPO4 -0.32 0.62665 0.01 0.97185 miRNAWalker2 validate -0.12 0.00096
80 hsa-let-7b-5p IRS2 -0.32 0.62665 0.49 0.07459 miRNAWalker2 validate; MirTarget; miRNATAP -0.23 0.01152
81 hsa-let-7b-5p KCTD12 -0.32 0.62665 0.28 0.43569 miRNAWalker2 validate -0.23 0.00451
82 hsa-let-7b-5p LIN28A -0.32 0.62665 0.14 0.68294 miRNAWalker2 validate; miRTarBase; miRNATAP -0.44 0.00055
83 hsa-let-7b-5p LIN28B -0.32 0.62665 0.69 0.08341 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.81 0
84 hsa-let-7b-5p MARS -0.32 0.62665 0.09 0.77495 miRNAWalker2 validate -0.07 0.00846
85 hsa-let-7b-5p MARS2 -0.32 0.62665 0.1 0.51838 miRNAWalker2 validate; MirTarget -0.12 0.01012
86 hsa-let-7b-5p MCM7 -0.32 0.62665 0.2 0.55007 miRNAWalker2 validate -0.1 0.01961
87 hsa-let-7b-5p MOV10 -0.32 0.62665 0.02 0.95271 miRNAWalker2 validate -0.08 0.01392
88 hsa-let-7b-5p MRPL47 -0.32 0.62665 0.31 0.21524 miRNAWalker2 validate -0.12 0.00647
89 hsa-let-7b-5p MSI1 -0.32 0.62665 0.3 0.26675 miRNAWalker2 validate -0.23 0.00873
90 hsa-let-7b-5p MSN -0.32 0.62665 0.19 0.62754 miRNAWalker2 validate -0.11 0.01307
91 hsa-let-7b-5p NCAPD2 -0.32 0.62665 0.2 0.51051 miRNAWalker2 validate -0.11 0.00618
92 hsa-let-7b-5p NRAS -0.32 0.62665 0.35 0.2078 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.16 0.00011
93 hsa-let-7b-5p NT5DC2 -0.32 0.62665 0.21 0.50055 miRNAWalker2 validate -0.13 0.01201
94 hsa-let-7b-5p OTUB1 -0.32 0.62665 0.11 0.73869 miRNAWalker2 validate -0.07 0.00952
95 hsa-let-7b-5p OXNAD1 -0.32 0.62665 0.18 0.24793 miRNAWalker2 validate -0.07 0.01521
96 hsa-let-7b-5p PFKM -0.32 0.62665 0.49 0.08122 miRNAWalker2 validate -0.23 4.0E-5
97 hsa-let-7b-5p PLAGL2 -0.32 0.62665 0.33 0.21488 miRNAWalker2 validate; MirTarget; miRNATAP -0.25 0
98 hsa-let-7b-5p PPARGC1A -0.32 0.62665 1.39 0 miRNAWalker2 validate; miRNATAP -0.39 0.00336
99 hsa-let-7b-5p PPM1G -0.32 0.62665 0.06 0.85145 miRNAWalker2 validate -0.1 0.00023
100 hsa-let-7b-5p PXDN -0.32 0.62665 0.7 0.04051 miRNAWalker2 validate; miRNATAP -0.28 0.00101
101 hsa-let-7b-5p QKI -0.32 0.62665 0.25 0.39568 miRNAWalker2 validate -0.12 0.00284
102 hsa-let-7b-5p RAP2C -0.32 0.62665 0.16 0.53518 miRNAWalker2 validate -0.13 0.0012
103 hsa-let-7b-5p SALL2 -0.32 0.62665 0.49 0.06655 miRNAWalker2 validate -0.35 0
104 hsa-let-7b-5p SCML2 -0.32 0.62665 0.53 0.0034 miRNAWalker2 validate -0.29 0.00034
105 hsa-let-7b-5p SCRN1 -0.32 0.62665 0.51 0.10708 miRNAWalker2 validate -0.36 0
106 hsa-let-7b-5p SLC25A13 -0.32 0.62665 0.16 0.52537 miRNAWalker2 validate -0.07 0.03336
107 hsa-let-7b-5p SLC38A1 -0.32 0.62665 0.51 0.13292 miRNAWalker2 validate -0.36 0
108 hsa-let-7b-5p STIP1 -0.32 0.62665 0.11 0.75572 miRNAWalker2 validate -0.06 0.04063
109 hsa-let-7b-5p TBRG4 -0.32 0.62665 0.13 0.64365 miRNAWalker2 validate -0.08 0.01431
110 hsa-let-7b-5p TIMM50 -0.32 0.62665 0.21 0.45674 miRNAWalker2 validate -0.16 8.0E-5
111 hsa-let-7b-5p TIMM8A -0.32 0.62665 0.22 0.15459 miRNAWalker2 validate -0.18 1.0E-5
112 hsa-let-7b-5p TUBB -0.32 0.62665 0.19 0.68436 miRNAWalker2 validate -0.09 0.00571
113 hsa-let-7b-5p TYMS -0.32 0.62665 0.3 0.20985 miRNAWalker2 validate -0.15 0.02975
114 hsa-let-7b-5p UNC13D -0.32 0.62665 0.39 0.10709 miRNAWalker2 validate -0.31 1.0E-5
115 hsa-let-7b-5p VAMP3 -0.32 0.62665 0.05 0.86593 miRNAWalker2 validate -0.07 0.01732
116 hsa-let-7b-5p XPO5 -0.32 0.62665 0.32 0.24236 miRNAWalker2 validate -0.16 0
117 hsa-let-7c-5p ACVR1B 0.09 0.87022 0.2 0.45588 miRNAWalker2 validate -0.08 0.00066
118 hsa-let-7c-5p CCNB2 0.09 0.87022 0.28 0.19628 miRNAWalker2 validate -0.28 0
119 hsa-let-7c-5p CCNF 0.09 0.87022 0.18 0.36539 miRNAWalker2 validate; MirTarget -0.18 0
120 hsa-let-7c-5p DOT1L 0.09 0.87022 -0.17 0.50094 miRNAWalker2 validate -0.09 6.0E-5
121 hsa-let-7c-5p FANCI 0.09 0.87022 0.12 0.61946 miRNAWalker2 validate -0.15 0
122 hsa-let-7c-5p GARS 0.09 0.87022 0.18 0.56669 miRNAWalker2 validate -0.12 0
123 hsa-let-7c-5p GPS1 0.09 0.87022 0.1 0.76082 miRNAWalker2 validate -0.06 0.00431
124 hsa-let-7c-5p IVNS1ABP 0.09 0.87022 -0.03 0.93862 miRNAWalker2 validate -0.16 0
125 hsa-let-7c-5p LDHA 0.09 0.87022 -0 1 miRNAWalker2 validate -0.22 0
126 hsa-let-7c-5p PSMB2 0.09 0.87022 0.1 0.73755 miRNAWalker2 validate -0.1 0
127 hsa-let-7c-5p PTGES2 0.09 0.87022 -0.09 0.74933 miRNAWalker2 validate -0.12 0
128 hsa-let-7c-5p RFWD3 0.09 0.87022 -0.06 0.81831 miRNAWalker2 validate -0.06 0.00283
129 hsa-let-7c-5p SLC25A1 0.09 0.87022 -0.05 0.87054 miRNAWalker2 validate -0.13 0
130 hsa-let-7c-5p TMEM165 0.09 0.87022 -0.24 0.42991 miRNAWalker2 validate -0.13 0
131 hsa-let-7c-5p TMEM184B 0.09 0.87022 -0.03 0.92074 miRNAWalker2 validate -0.13 0
132 hsa-let-7d-5p ARRDC4 -0.03 0.94154 -0.43 0.08457 miRNAWalker2 validate; MirTarget; miRNATAP -0.29 2.0E-5
133 hsa-let-7d-5p CALCOCO2 -0.03 0.94154 -0.05 0.8568 miRNAWalker2 validate -0.16 0
134 hsa-let-7d-5p CEP120 -0.03 0.94154 0.02 0.92757 miRNAWalker2 validate; MirTarget; miRNATAP -0.21 0
135 hsa-let-7d-5p DLC1 -0.03 0.94154 -0.17 0.50323 miRNAWalker2 validate -0.31 0
136 hsa-let-7d-5p FBXO3 -0.03 0.94154 -0.11 0.64071 miRNAWalker2 validate -0.15 5.0E-5
137 hsa-let-7d-5p GPR137B -0.03 0.94154 0.18 0.38036 miRNAWalker2 validate -0.18 0.00228
138 hsa-let-7d-5p KATNAL1 -0.03 0.94154 0.19 0.31272 miRNAWalker2 validate -0.26 1.0E-5
139 hsa-let-7d-5p KPNA5 -0.03 0.94154 -0.03 0.78497 miRNAWalker2 validate -0.17 0.00069
140 hsa-let-7d-5p LIN28B -0.03 0.94154 0.69 0.08341 miRNAWalker2 validate; MirTarget; miRNATAP -0.77 9.0E-5
141 hsa-let-7d-5p MPL -0.03 0.94154 0.13 0.23977 miRNAWalker2 validate -0.13 0.02433
142 hsa-let-7d-5p NCOA1 -0.03 0.94154 0.03 0.92238 miRNAWalker2 validate; miRNATAP -0.07 0.03724
143 hsa-let-7d-5p NR4A1 -0.03 0.94154 -0.01 0.97894 miRNAWalker2 validate -0.27 0.0024
144 hsa-let-7d-5p PCNP -0.03 0.94154 0.25 0.44517 miRNAWalker2 validate -0.22 0
145 hsa-let-7d-5p TGFBR1 -0.03 0.94154 0.14 0.59918 miRNAWalker2 validate; miRNATAP -0.19 0
146 hsa-let-7d-5p THBS1 -0.03 0.94154 0.13 0.72998 miRNAWalker2 validate -0.49 0
147 hsa-let-7e-5p AEBP2 -0.01 0.98568 0.07 0.76569 miRNAWalker2 validate -0.09 0.02739
148 hsa-let-7e-5p ANKRD40 -0.01 0.98568 0.09 0.72676 miRNAWalker2 validate -0.16 0
149 hsa-let-7e-5p BAHCC1 -0.01 0.98568 -0.04 0.8942 miRNAWalker2 validate -0.35 0.00224
150 hsa-let-7e-5p CA5B -0.01 0.98568 -0.22 0.26363 miRNAWalker2 validate -0.28 0

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 713 1672 3.697e-40 1.72e-36
2 CELL DEVELOPMENT 626 1426 1.072e-39 2.493e-36
3 CARDIOVASCULAR SYSTEM DEVELOPMENT 392 788 5.312e-39 6.18e-36
4 CIRCULATORY SYSTEM DEVELOPMENT 392 788 5.312e-39 6.18e-36
5 TISSUE DEVELOPMENT 651 1518 1.913e-37 1.781e-34
6 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 513 1142 1.566e-35 1.215e-32
7 RESPONSE TO OXYGEN CONTAINING COMPOUND 593 1381 3.316e-34 2.204e-31
8 NEUROGENESIS 600 1402 4.05e-34 2.356e-31
9 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 597 1395 6.067e-34 3.137e-31
10 BIOLOGICAL ADHESION 467 1032 2.923e-33 1.36e-30
11 VASCULATURE DEVELOPMENT 254 469 6.209e-33 2.626e-30
12 RESPONSE TO ENDOGENOUS STIMULUS 612 1450 9.49e-33 3.68e-30
13 ORGAN MORPHOGENESIS 393 841 1.417e-31 5.071e-29
14 REGULATION OF CELL DIFFERENTIATION 616 1492 8.705e-30 2.893e-27
15 REGULATION OF CELL PROLIFERATION 616 1496 2.067e-29 6.411e-27
16 BLOOD VESSEL MORPHOGENESIS 203 364 9.064e-29 2.636e-26
17 REGULATION OF CELLULAR COMPONENT MOVEMENT 359 771 1.621e-28 4.436e-26
18 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 369 799 1.961e-28 5.068e-26
19 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 448 1021 3.006e-28 7.361e-26
20 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 729 1848 3.545e-28 8.246e-26
21 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 441 1008 1.762e-27 3.904e-25
22 POSITIVE REGULATION OF MOLECULAR FUNCTION 702 1791 3.511e-26 7.425e-24
23 UROGENITAL SYSTEM DEVELOPMENT 171 299 4.14e-26 8.376e-24
24 POSITIVE REGULATION OF CELL DIFFERENTIATION 369 823 1.945e-25 3.772e-23
25 POSITIVE REGULATION OF CELL COMMUNICATION 613 1532 2.05e-25 3.816e-23
26 LOCOMOTION 471 1114 2.312e-25 4.138e-23
27 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 525 1275 4.899e-25 8.443e-23
28 INTRACELLULAR SIGNAL TRANSDUCTION 621 1572 4.28e-24 7.113e-22
29 POSITIVE REGULATION OF CATALYTIC ACTIVITY 602 1518 7.834e-24 1.257e-21
30 ANGIOGENESIS 163 293 3.417e-23 5.3e-21
31 RESPONSE TO ABIOTIC STIMULUS 432 1024 4.498e-23 6.697e-21
32 CENTRAL NERVOUS SYSTEM DEVELOPMENT 379 872 4.605e-23 6.697e-21
33 EPITHELIUM DEVELOPMENT 404 945 6.749e-23 9.516e-21
34 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 407 957 1.497e-22 2.049e-20
35 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 247 513 2.434e-22 3.236e-20
36 POSITIVE REGULATION OF HYDROLASE ACTIVITY 387 905 5.489e-22 6.964e-20
37 REGULATION OF TRANSPORT 688 1804 5.538e-22 6.964e-20
38 NEURON DIFFERENTIATION 376 874 6.203e-22 7.596e-20
39 RESPONSE TO HORMONE 382 893 9.598e-22 1.145e-19
40 REGULATION OF PHOSPHORUS METABOLIC PROCESS 626 1618 1.073e-21 1.248e-19
41 NEGATIVE REGULATION OF CELL COMMUNICATION 483 1192 2.386e-21 2.708e-19
42 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 539 1360 2.818e-21 3.122e-19
43 SKELETAL SYSTEM DEVELOPMENT 222 455 4.26e-21 4.609e-19
44 EMBRYO DEVELOPMENT 379 894 9.202e-21 9.732e-19
45 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 328 750 1.389e-20 1.41e-18
46 MUSCLE STRUCTURE DEVELOPMENT 212 432 1.394e-20 1.41e-18
47 REGULATION OF CELL DEVELOPMENT 358 836 1.602e-20 1.586e-18
48 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 632 1656 2.899e-20 2.81e-18
49 RESPONSE TO ORGANIC CYCLIC COMPOUND 385 917 3.335e-20 3.104e-18
50 RESPONSE TO LIPID 375 888 3.292e-20 3.104e-18
51 POSITIVE REGULATION OF CELL PROLIFERATION 349 814 3.947e-20 3.601e-18
52 REGULATION OF HYDROLASE ACTIVITY 522 1327 7.963e-20 6.991e-18
53 REGULATION OF EPITHELIAL CELL PROLIFERATION 153 285 7.854e-20 6.991e-18
54 NEURON PROJECTION DEVELOPMENT 252 545 8.437e-20 7.27e-18
55 REGULATION OF CELL DEATH 569 1472 1.246e-19 1.054e-17
56 TUBE DEVELOPMENT 254 552 1.326e-19 1.102e-17
57 NEURON PROJECTION MORPHOGENESIS 198 402 1.562e-19 1.275e-17
58 HEAD DEVELOPMENT 310 709 1.72e-19 1.38e-17
59 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 675 1805 3.672e-19 2.896e-17
60 REGULATION OF SYSTEM PROCESS 236 507 4.607e-19 3.573e-17
61 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 421 1036 6.013e-19 4.513e-17
62 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 421 1036 6.013e-19 4.513e-17
63 MORPHOGENESIS OF A BRANCHING STRUCTURE 102 167 6.22e-19 4.594e-17
64 CELL PROLIFERATION 295 672 6.752e-19 4.909e-17
65 TISSUE MORPHOGENESIS 245 533 7.027e-19 5.03e-17
66 CELL MOTILITY 351 835 1.351e-18 9.386e-17
67 LOCALIZATION OF CELL 351 835 1.351e-18 9.386e-17
68 RESPONSE TO NITROGEN COMPOUND 359 859 1.616e-18 1.106e-16
69 NEURON DEVELOPMENT 299 687 1.718e-18 1.142e-16
70 CELLULAR COMPONENT MORPHOGENESIS 373 900 1.699e-18 1.142e-16
71 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 401 983 2.037e-18 1.321e-16
72 RESPONSE TO ALCOHOL 180 362 2.044e-18 1.321e-16
73 RESPONSE TO WOUNDING 254 563 3.082e-18 1.964e-16
74 POSITIVE REGULATION OF RESPONSE TO STIMULUS 709 1929 4.984e-18 3.134e-16
75 HEART DEVELOPMENT 218 466 5.165e-18 3.204e-16
76 REGULATION OF NEURON DIFFERENTIATION 249 554 1.186e-17 7.26e-16
77 POSITIVE REGULATION OF GENE EXPRESSION 644 1733 1.404e-17 8.484e-16
78 REGULATION OF GTPASE ACTIVITY 291 673 1.482e-17 8.84e-16
79 CELL CELL ADHESION 268 608 1.502e-17 8.845e-16
80 REGULATION OF BLOOD CIRCULATION 152 295 1.552e-17 9.03e-16
81 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 658 1784 4.036e-17 2.319e-15
82 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 295 689 4.476e-17 2.54e-15
83 EMBRYONIC ORGAN DEVELOPMENT 193 406 5.406e-17 3.031e-15
84 CELLULAR RESPONSE TO NITROGEN COMPOUND 229 505 7.064e-17 3.888e-15
85 POSITIVE REGULATION OF CELL DEVELOPMENT 217 472 7.103e-17 3.888e-15
86 EMBRYONIC MORPHOGENESIS 241 539 8.569e-17 4.636e-15
87 REGULATION OF KINASE ACTIVITY 324 776 9.719e-17 5.198e-15
88 REGULATION OF ION TRANSPORT 259 592 1.65e-16 8.725e-15
89 REGULATION OF PROTEIN MODIFICATION PROCESS 631 1710 1.777e-16 9.291e-15
90 REGULATION OF HEART CONTRACTION 120 221 2.364e-16 1.222e-14
91 TUBE MORPHOGENESIS 160 323 2.499e-16 1.278e-14
92 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 559 1492 4.255e-16 2.152e-14
93 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 201 437 9.423e-16 4.714e-14
94 RESPONSE TO EXTERNAL STIMULUS 662 1821 1.178e-15 5.833e-14
95 ION TRANSPORT 482 1262 1.266e-15 6.203e-14
96 MORPHOGENESIS OF AN EPITHELIUM 187 400 1.329e-15 6.441e-14
97 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 307 740 1.786e-15 8.568e-14
98 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 710 1977 2.039e-15 9.68e-14
99 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 353 876 2.108e-15 9.909e-14
100 CELLULAR RESPONSE TO HORMONE STIMULUS 241 552 2.536e-15 1.18e-13
101 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 327 801 2.986e-15 1.376e-13
102 PROTEIN PHOSPHORYLATION 375 944 3.408e-15 1.555e-13
103 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 395 1004 3.449e-15 1.558e-13
104 REGULATION OF CELLULAR LOCALIZATION 484 1277 5.182e-15 2.318e-13
105 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 437 1135 6.829e-15 3.026e-13
106 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 173 368 8.198e-15 3.599e-13
107 STEM CELL DIFFERENTIATION 104 190 1.133e-14 4.928e-13
108 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 79 131 1.499e-14 6.458e-13
109 TAXIS 207 464 1.746e-14 7.384e-13
110 CELL PROJECTION ORGANIZATION 358 902 1.732e-14 7.384e-13
111 EXTRACELLULAR STRUCTURE ORGANIZATION 148 304 2.067e-14 8.664e-13
112 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 119 229 2.226e-14 9.246e-13
113 CELLULAR RESPONSE TO LIPID 204 457 2.515e-14 1.036e-12
114 RESPONSE TO GROWTH FACTOR 210 475 3.482e-14 1.421e-12
115 POSITIVE REGULATION OF NEURON DIFFERENTIATION 148 306 4.081e-14 1.623e-12
116 WOUND HEALING 208 470 4.076e-14 1.623e-12
117 REGULATION OF OSSIFICATION 98 178 4.028e-14 1.623e-12
118 REGULATION OF TRANSFERASE ACTIVITY 371 946 4.283e-14 1.689e-12
119 BEHAVIOR 224 516 5.149e-14 2.013e-12
120 REGULATION OF MAPK CASCADE 274 660 5.57e-14 2.16e-12
121 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 438 1152 6.51e-14 2.504e-12
122 CONNECTIVE TISSUE DEVELOPMENT 104 194 6.993e-14 2.667e-12
123 REGULATION OF GROWTH 264 633 8.672e-14 3.281e-12
124 RESPONSE TO OXYGEN LEVELS 149 311 8.884e-14 3.334e-12
125 NEGATIVE REGULATION OF GENE EXPRESSION 547 1493 1.045e-13 3.89e-12
126 CELLULAR HOMEOSTASIS 278 676 1.388e-13 5.125e-12
127 POSITIVE REGULATION OF MAPK CASCADE 206 470 1.732e-13 6.347e-12
128 GLAND DEVELOPMENT 179 395 1.887e-13 6.858e-12
129 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 204 465 2.034e-13 7.336e-12
130 POSITIVE REGULATION OF KINASE ACTIVITY 210 482 2.073e-13 7.362e-12
131 EMBRYONIC ORGAN MORPHOGENESIS 136 279 2.071e-13 7.362e-12
132 CELL PART MORPHOGENESIS 262 633 3.019e-13 1.061e-11
133 REGULATION OF CELL MORPHOGENESIS 234 552 3.033e-13 1.061e-11
134 EPITHELIAL CELL DIFFERENTIATION 214 495 3.125e-13 1.085e-11
135 MUSCLE TISSUE DEVELOPMENT 134 275 3.22e-13 1.11e-11
136 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 215 498 3.248e-13 1.111e-11
137 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 86 154 4.952e-13 1.682e-11
138 REGULATION OF CELL PROJECTION ORGANIZATION 235 558 6.148e-13 2.073e-11
139 HEART MORPHOGENESIS 109 212 6.716e-13 2.248e-11
140 AGING 129 264 6.868e-13 2.283e-11
141 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 550 1517 7.317e-13 2.415e-11
142 RESPONSE TO KETONE 97 182 7.646e-13 2.505e-11
143 REGULATION OF VASCULATURE DEVELOPMENT 117 233 7.869e-13 2.561e-11
144 POSITIVE REGULATION OF LOCOMOTION 186 420 8.457e-13 2.733e-11
145 NEURON PROJECTION GUIDANCE 106 205 8.706e-13 2.794e-11
146 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 233 554 9.128e-13 2.909e-11
147 MESENCHYME DEVELOPMENT 100 190 9.398e-13 2.955e-11
148 REGULATION OF TRANSMEMBRANE TRANSPORT 188 426 9.378e-13 2.955e-11
149 REGULATION OF MEMBRANE POTENTIAL 158 343 9.657e-13 3.016e-11
150 CIRCULATORY SYSTEM PROCESS 166 366 1.299e-12 4.028e-11
151 POSITIVE REGULATION OF CELL DEATH 250 605 1.316e-12 4.055e-11
152 KIDNEY EPITHELIUM DEVELOPMENT 73 125 1.426e-12 4.365e-11
153 SENSORY ORGAN DEVELOPMENT 211 493 1.497e-12 4.552e-11
154 MUSCLE ORGAN DEVELOPMENT 133 277 1.545e-12 4.667e-11
155 RESPONSE TO STEROID HORMONE 212 497 1.956e-12 5.871e-11
156 NEGATIVE REGULATION OF CELL DEATH 339 872 2.114e-12 6.304e-11
157 REGULATION OF BODY FLUID LEVELS 215 506 2.149e-12 6.369e-11
158 REGULATION OF CELL ADHESION 257 629 2.726e-12 8.029e-11
159 CHEMICAL HOMEOSTASIS 339 874 2.968e-12 8.684e-11
160 MUSCLE SYSTEM PROCESS 134 282 3.294e-12 9.579e-11
161 MUSCLE CELL DIFFERENTIATION 117 237 3.383e-12 9.777e-11
162 NEPHRON DEVELOPMENT 68 115 3.697e-12 1.062e-10
163 CELL CELL SIGNALING 303 767 3.731e-12 1.065e-10
164 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 104 204 4.432e-12 1.257e-10
165 CELLULAR CHEMICAL HOMEOSTASIS 236 570 4.463e-12 1.259e-10
166 OSSIFICATION 122 251 4.532e-12 1.27e-10
167 METAL ION TRANSPORT 240 582 4.796e-12 1.336e-10
168 GROWTH 180 410 4.936e-12 1.367e-10
169 REGULATION OF CELLULAR COMPONENT BIOGENESIS 302 767 6.384e-12 1.758e-10
170 KIDNEY MORPHOGENESIS 53 82 6.833e-12 1.87e-10
171 REGULATION OF MUSCLE SYSTEM PROCESS 100 195 7.233e-12 1.968e-10
172 SINGLE ORGANISM BEHAVIOR 170 384 8.383e-12 2.268e-10
173 REGULATION OF OSTEOBLAST DIFFERENTIATION 66 112 9.486e-12 2.551e-10
174 POSITIVE REGULATION OF TRANSPORT 357 936 9.8e-12 2.621e-10
175 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 200 470 1.078e-11 2.866e-10
176 PALATE DEVELOPMENT 54 85 1.186e-11 3.135e-10
177 REGULATION OF NEURON PROJECTION DEVELOPMENT 178 408 1.235e-11 3.246e-10
178 REGULATION OF SECRETION 278 699 1.255e-11 3.281e-10
179 NEGATIVE REGULATION OF CELL PROLIFERATION 259 643 1.355e-11 3.522e-10
180 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 245 602 1.432e-11 3.702e-10
181 CATION TRANSPORT 310 796 1.515e-11 3.894e-10
182 MODULATION OF SYNAPTIC TRANSMISSION 139 301 1.778e-11 4.545e-10
183 PHOSPHORYLATION 450 1228 1.918e-11 4.876e-10
184 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 104 208 2.014e-11 5.092e-10
185 ION TRANSMEMBRANE TRANSPORT 318 822 2.063e-11 5.189e-10
186 TRANSMEMBRANE TRANSPORT 408 1098 2.11e-11 5.278e-10
187 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 249 616 2.219e-11 5.495e-10
188 REGULATION OF CYTOSKELETON ORGANIZATION 210 502 2.22e-11 5.495e-10
189 FOREBRAIN DEVELOPMENT 159 357 2.237e-11 5.507e-10
190 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 113 232 2.335e-11 5.718e-10
191 POSITIVE REGULATION OF OSSIFICATION 53 84 2.701e-11 6.58e-10
192 CELL DEATH 376 1001 2.765e-11 6.701e-10
193 ACTIVATION OF PROTEIN KINASE ACTIVITY 130 279 3.745e-11 9.029e-10
194 NEGATIVE REGULATION OF CELL DIFFERENTIATION 245 609 5.641e-11 1.353e-09
195 CARTILAGE DEVELOPMENT 79 147 5.793e-11 1.382e-09
196 HOMEOSTATIC PROCESS 482 1337 5.874e-11 1.394e-09
197 DEVELOPMENTAL GROWTH 149 333 6.252e-11 1.477e-09
198 MESONEPHROS DEVELOPMENT 55 90 7.016e-11 1.649e-09
199 RESPONSE TO PEPTIDE 174 404 7.438e-11 1.739e-09
200 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 150 337 8.656e-11 2.014e-09
201 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 81 153 9.006e-11 2.085e-09
202 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 102 207 9.265e-11 2.134e-09
203 MESENCHYMAL CELL DIFFERENTIATION 73 134 1.332e-10 3.038e-09
204 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 58 98 1.331e-10 3.038e-09
205 REGULATION OF METAL ION TRANSPORT 145 325 1.448e-10 3.287e-09
206 SKELETAL SYSTEM MORPHOGENESIS 99 201 1.796e-10 4.056e-09
207 REGULATION OF ACTIN FILAMENT BASED PROCESS 140 312 1.845e-10 4.146e-09
208 REPRODUCTIVE SYSTEM DEVELOPMENT 174 408 1.914e-10 4.282e-09
209 REGULATION OF CELL GROWTH 168 391 1.968e-10 4.381e-09
210 MULTICELLULAR ORGANISMAL SIGNALING 68 123 2.399e-10 5.316e-09
211 REGULATION OF ORGAN MORPHOGENESIS 114 242 2.585e-10 5.701e-09
212 REGULATION OF MAP KINASE ACTIVITY 142 319 2.714e-10 5.957e-09
213 ION HOMEOSTASIS 231 576 2.829e-10 6.179e-09
214 SINGLE ORGANISM CELL ADHESION 191 459 3.017e-10 6.56e-09
215 NEGATIVE REGULATION OF PHOSPHORYLATION 178 422 3.41e-10 7.379e-09
216 REGULATION OF ANATOMICAL STRUCTURE SIZE 195 472 4.04e-10 8.703e-09
217 SPROUTING ANGIOGENESIS 33 45 4.226e-10 9.062e-09
218 PATTERN SPECIFICATION PROCESS 176 418 5.054e-10 1.079e-08
219 ACTIN FILAMENT BASED PROCESS 187 450 5.274e-10 1.121e-08
220 RESPONSE TO MECHANICAL STIMULUS 101 210 6.417e-10 1.357e-08
221 RESPONSE TO PURINE CONTAINING COMPOUND 81 158 7.037e-10 1.482e-08
222 REGULATION OF HORMONE LEVELS 196 478 7.65e-10 1.603e-08
223 REGULATION OF HORMONE SECRETION 120 262 7.839e-10 1.636e-08
224 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 66 121 9.398e-10 1.952e-08
225 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 217 541 9.656e-10 1.988e-08
226 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 217 541 9.656e-10 1.988e-08
227 CELL SUBSTRATE ADHESION 83 164 9.826e-10 2.014e-08
228 NEGATIVE REGULATION OF LOCOMOTION 120 263 1.045e-09 2.123e-08
229 CELLULAR RESPONSE TO PEPTIDE 124 274 1.04e-09 2.123e-08
230 REGULATION OF ION HOMEOSTASIS 97 201 1.106e-09 2.238e-08
231 METANEPHROS DEVELOPMENT 49 81 1.246e-09 2.511e-08
232 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 264 684 1.417e-09 2.842e-08
233 NEPHRON EPITHELIUM DEVELOPMENT 54 93 1.519e-09 3.034e-08
234 REGULATION OF CELL CYCLE 350 949 1.639e-09 3.26e-08
235 RESPONSE TO INORGANIC SUBSTANCE 195 479 1.693e-09 3.352e-08
236 RESPIRATORY SYSTEM DEVELOPMENT 95 197 1.717e-09 3.37e-08
237 REGULATION OF ORGANELLE ORGANIZATION 423 1178 1.714e-09 3.37e-08
238 REGULATED EXOCYTOSIS 105 224 1.827e-09 3.573e-08
239 CELLULAR RESPONSE TO OXYGEN LEVELS 74 143 2.204e-09 4.291e-08
240 CARDIAC CONDUCTION 49 82 2.251e-09 4.364e-08
241 RESPONSE TO ESTRADIOL 75 146 2.639e-09 5.093e-08
242 IN UTERO EMBRYONIC DEVELOPMENT 136 311 2.649e-09 5.093e-08
243 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 133 303 2.961e-09 5.669e-08
244 CELLULAR RESPONSE TO ACID CHEMICAL 86 175 3.161e-09 6.002e-08
245 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 58 104 3.16e-09 6.002e-08
246 RENAL TUBULE DEVELOPMENT 47 78 3.245e-09 6.137e-08
247 NEGATIVE REGULATION OF CELL CYCLE 178 433 3.642e-09 6.86e-08
248 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 392 1087 3.927e-09 7.369e-08
249 LOCOMOTORY BEHAVIOR 88 181 4.071e-09 7.607e-08
250 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 122 274 4.711e-09 8.768e-08
251 EAR DEVELOPMENT 93 195 5.142e-09 9.532e-08
252 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 53 93 5.349e-09 9.877e-08
253 REGULATION OF HOMEOSTATIC PROCESS 182 447 5.796e-09 1.066e-07
254 CELL CYCLE 463 1316 6.285e-09 1.151e-07
255 CELLULAR RESPONSE TO EXTERNAL STIMULUS 118 264 6.379e-09 1.164e-07
256 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 42 68 7.784e-09 1.415e-07
257 RESPONSE TO ESTROGEN 101 218 7.97e-09 1.443e-07
258 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 178 437 8.205e-09 1.48e-07
259 CYTOSKELETON ORGANIZATION 310 838 1.015e-08 1.823e-07
260 REGULATION OF MUSCLE CONTRACTION 74 147 1.048e-08 1.875e-07
261 TELENCEPHALON DEVELOPMENT 104 228 1.347e-08 2.401e-07
262 REGULATION OF SYNAPTIC PLASTICITY 71 140 1.392e-08 2.462e-07
263 CARDIAC MUSCLE TISSUE DEVELOPMENT 71 140 1.392e-08 2.462e-07
264 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 137 321 1.502e-08 2.647e-07
265 CELLULAR RESPONSE TO ALCOHOL 61 115 1.653e-08 2.902e-07
266 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 68 133 1.833e-08 3.206e-07
267 REPRODUCTION 454 1297 1.846e-08 3.217e-07
268 MUSCLE CELL DEVELOPMENT 66 128 1.918e-08 3.33e-07
269 SECRETION 227 588 1.976e-08 3.405e-07
270 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 14 14 1.973e-08 3.405e-07
271 IMMUNE SYSTEM DEVELOPMENT 225 582 1.992e-08 3.42e-07
272 LEARNING 67 131 2.286e-08 3.91e-07
273 REGULATION OF CELL SUBSTRATE ADHESION 83 173 2.393e-08 4.078e-07
274 EYE DEVELOPMENT 138 326 2.457e-08 4.172e-07
275 REGULATION OF DEVELOPMENTAL GROWTH 125 289 2.503e-08 4.235e-07
276 MUSCLE CONTRACTION 105 233 2.527e-08 4.26e-07
277 PLASMA MEMBRANE ORGANIZATION 94 203 2.675e-08 4.493e-07
278 SENSORY ORGAN MORPHOGENESIS 107 239 2.861e-08 4.789e-07
279 NEUROTRANSMITTER TRANSPORT 76 155 2.873e-08 4.792e-07
280 REGULATION OF INTRACELLULAR TRANSPORT 237 621 3.03e-08 5.035e-07
281 REGULATION OF TRANSPORTER ACTIVITY 92 198 3.052e-08 5.053e-07
282 ARTERY DEVELOPMENT 44 75 3.197e-08 5.274e-07
283 REGULATION OF VESICLE MEDIATED TRANSPORT 184 462 3.326e-08 5.469e-07
284 COGNITION 111 251 3.585e-08 5.874e-07
285 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 63 122 3.716e-08 6.024e-07
286 APPENDAGE DEVELOPMENT 81 169 3.711e-08 6.024e-07
287 LIMB DEVELOPMENT 81 169 3.711e-08 6.024e-07
288 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 335 926 3.837e-08 6.2e-07
289 POSITIVE REGULATION OF MAP KINASE ACTIVITY 95 207 3.888e-08 6.26e-07
290 CELL GROWTH 68 135 3.951e-08 6.34e-07
291 REGIONALIZATION 132 311 4.062e-08 6.495e-07
292 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 104 232 4.101e-08 6.536e-07
293 RESPONSE TO DRUG 173 431 4.503e-08 7.15e-07
294 NEGATIVE REGULATION OF MOLECULAR FUNCTION 383 1079 4.627e-08 7.322e-07
295 SMOOTH MUSCLE CELL DIFFERENTIATION 23 30 4.936e-08 7.785e-07
296 POSITIVE REGULATION OF CELL ADHESION 154 376 5.368e-08 8.438e-07
297 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 234 616 5.792e-08 9.074e-07
298 REGULATION OF PEPTIDE TRANSPORT 112 256 6.29e-08 9.821e-07
299 RESPONSE TO ACID CHEMICAL 134 319 6.749e-08 1.05e-06
300 CARDIOCYTE DIFFERENTIATION 52 96 7.477e-08 1.16e-06
301 REGULATION OF EPITHELIAL CELL MIGRATION 79 166 7.969e-08 1.232e-06
302 REGULATION OF ENDOTHELIAL CELL MIGRATION 59 114 8.979e-08 1.383e-06
303 SEX DIFFERENTIATION 115 266 9.176e-08 1.409e-06
304 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 53 99 9.429e-08 1.443e-06
305 MONOVALENT INORGANIC CATION TRANSPORT 173 435 9.511e-08 1.451e-06
306 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 123 289 9.664e-08 1.47e-06
307 CELLULAR RESPONSE TO STRESS 532 1565 9.729e-08 1.475e-06
308 INORGANIC ION TRANSMEMBRANE TRANSPORT 222 583 1.014e-07 1.532e-06
309 ANTERIOR POSTERIOR PATTERN SPECIFICATION 89 194 1.052e-07 1.585e-06
310 PEPTIDYL TYROSINE MODIFICATION 86 186 1.114e-07 1.673e-06
311 GLAND MORPHOGENESIS 52 97 1.172e-07 1.748e-06
312 REGULATION OF CYTOPLASMIC TRANSPORT 188 481 1.172e-07 1.748e-06
313 MEMBRANE DEPOLARIZATION 37 61 1.186e-07 1.757e-06
314 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 68 138 1.184e-07 1.757e-06
315 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 77 162 1.235e-07 1.824e-06
316 AMEBOIDAL TYPE CELL MIGRATION 74 154 1.241e-07 1.828e-06
317 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 92 203 1.306e-07 1.917e-06
318 REGULATION OF RESPONSE TO WOUNDING 165 413 1.317e-07 1.928e-06
319 STRIATED MUSCLE CELL DIFFERENTIATION 81 173 1.327e-07 1.935e-06
320 NEGATIVE REGULATION OF TRANSPORT 180 458 1.392e-07 2.024e-06
321 VASCULOGENESIS 36 59 1.417e-07 2.054e-06
322 HEMOSTASIS 130 311 1.472e-07 2.127e-06
323 REGULATION OF CALCIUM ION TRANSPORT 94 209 1.489e-07 2.132e-06
324 DIVALENT INORGANIC CATION HOMEOSTASIS 141 343 1.489e-07 2.132e-06
325 REGULATION OF PEPTIDE SECRETION 94 209 1.489e-07 2.132e-06
326 SECOND MESSENGER MEDIATED SIGNALING 76 160 1.537e-07 2.194e-06
327 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 144 352 1.562e-07 2.222e-06
328 REGULATION OF NEUROTRANSMITTER LEVELS 87 190 1.616e-07 2.292e-06
329 REGULATION OF STEM CELL DIFFERENTIATION 58 113 1.672e-07 2.364e-06
330 RESPONSE TO ORGANOPHOSPHORUS 68 139 1.683e-07 2.373e-06
331 CELL CYCLE PROCESS 380 1081 1.714e-07 2.409e-06
332 REGULATION OF MUSCLE TISSUE DEVELOPMENT 54 103 1.79e-07 2.509e-06
333 FEMALE SEX DIFFERENTIATION 59 116 1.981e-07 2.768e-06
334 RHYTHMIC PROCESS 125 298 2.017e-07 2.809e-06
335 SYNAPSE ORGANIZATION 70 145 2.145e-07 2.979e-06
336 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 29 44 2.155e-07 2.984e-06
337 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 33 53 2.372e-07 3.265e-06
338 MESONEPHRIC TUBULE MORPHOGENESIS 33 53 2.372e-07 3.265e-06
339 PROTEIN LOCALIZATION TO CELL PERIPHERY 72 151 2.674e-07 3.67e-06
340 CELL ACTIVATION 215 568 2.711e-07 3.688e-06
341 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 112 262 2.708e-07 3.688e-06
342 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 61 122 2.707e-07 3.688e-06
343 ARTERY MORPHOGENESIS 32 51 2.794e-07 3.79e-06
344 MAMMARY GLAND DEVELOPMENT 59 117 2.904e-07 3.928e-06
345 EAR MORPHOGENESIS 57 112 3.087e-07 4.163e-06
346 DEVELOPMENTAL CELL GROWTH 43 77 3.175e-07 4.269e-06
347 REGULATION OF BINDING 119 283 3.352e-07 4.495e-06
348 REGULATION OF RESPONSE TO STRESS 498 1468 3.428e-07 4.584e-06
349 REGULATION OF AXONOGENESIS 78 168 3.448e-07 4.598e-06
350 RESPONSE TO ETHANOL 66 136 3.696e-07 4.899e-06
351 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 72 152 3.689e-07 4.899e-06
352 REGULATION OF PROTEIN SECRETION 155 389 3.788e-07 5.008e-06
353 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 117 278 3.97e-07 5.233e-06
354 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 52 100 4.211e-07 5.535e-06
355 ENDOTHELIUM DEVELOPMENT 48 90 4.351e-07 5.671e-06
356 MULTI MULTICELLULAR ORGANISM PROCESS 94 213 4.327e-07 5.671e-06
357 REGULATION OF CELL MATRIX ADHESION 48 90 4.351e-07 5.671e-06
358 REGULATION OF WOUND HEALING 62 126 4.471e-07 5.812e-06
359 SECRETION BY CELL 187 486 4.495e-07 5.826e-06
360 REGULATION OF SYNAPSE ORGANIZATION 57 113 4.527e-07 5.851e-06
361 CELLULAR RESPONSE TO KETONE 41 73 4.826e-07 6.221e-06
362 REGULATION OF MUSCLE ORGAN DEVELOPMENT 53 103 5.058e-07 6.501e-06
363 REGULATION OF STEM CELL PROLIFERATION 47 88 5.413e-07 6.939e-06
364 SYNAPTIC SIGNALING 166 424 5.591e-07 7.147e-06
365 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 27 41 5.814e-07 7.412e-06
366 NEGATIVE REGULATION OF CELL DEVELOPMENT 125 303 5.904e-07 7.506e-06
367 REGULATION OF CELLULAR RESPONSE TO STRESS 253 691 6.113e-07 7.751e-06
368 IMMUNE SYSTEM PROCESS 653 1984 6.435e-07 8.114e-06
369 CALCIUM ION TRANSPORT 97 223 6.43e-07 8.114e-06
370 REGULATION OF PHOSPHOLIPASE ACTIVITY 37 64 6.538e-07 8.222e-06
371 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 26 39 6.574e-07 8.244e-06
372 APOPTOTIC SIGNALING PATHWAY 120 289 6.605e-07 8.262e-06
373 REGULATION OF HEART RATE 46 86 6.734e-07 8.401e-06
374 POTASSIUM ION TRANSPORT 72 154 6.899e-07 8.583e-06
375 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 25 37 7.349e-07 9.095e-06
376 CARDIAC MUSCLE CELL ACTION POTENTIAL 25 37 7.349e-07 9.095e-06
377 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 95 218 7.551e-07 9.32e-06
378 CARDIAC MUSCLE CELL DIFFERENTIATION 41 74 7.883e-07 9.703e-06
379 REGULATION OF KIDNEY DEVELOPMENT 33 55 8.116e-07 9.964e-06
380 ACTION POTENTIAL 49 94 8.172e-07 1.001e-05
381 REGULATION OF MUSCLE CELL DIFFERENTIATION 71 152 8.575e-07 1.047e-05
382 REGULATION OF SEQUESTERING OF CALCIUM ION 54 107 8.817e-07 1.074e-05
383 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 68 144 8.851e-07 1.075e-05
384 POSITIVE REGULATION OF SECRETION 147 370 9.135e-07 1.107e-05
385 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 52 102 9.366e-07 1.132e-05
386 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 159 406 9.406e-07 1.134e-05
387 POSITIVE REGULATION OF ION TRANSPORT 101 236 9.581e-07 1.149e-05
388 NEGATIVE REGULATION OF GROWTH 101 236 9.581e-07 1.149e-05
389 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 32 53 9.765e-07 1.165e-05
390 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 35 60 9.74e-07 1.165e-05
391 ENDOCRINE SYSTEM DEVELOPMENT 60 123 9.886e-07 1.176e-05
392 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 48 92 1.019e-06 1.21e-05
393 REGULATION OF BLOOD PRESSURE 77 169 1.031e-06 1.22e-05
394 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 37 65 1.107e-06 1.307e-05
395 RESPONSE TO RADIATION 161 413 1.117e-06 1.316e-05
396 ANION TRANSPORT 192 507 1.121e-06 1.317e-05
397 RESPONSE TO METAL ION 134 333 1.216e-06 1.426e-05
398 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 95 220 1.235e-06 1.444e-05
399 NEURAL CREST CELL DIFFERENTIATION 41 75 1.267e-06 1.477e-05
400 PROTEIN AUTOPHOSPHORYLATION 85 192 1.288e-06 1.498e-05
401 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 57 116 1.356e-06 1.565e-05
402 PRESYNAPTIC PROCESS INVOLVED IN SYNAPTIC TRANSMISSION 57 116 1.356e-06 1.565e-05
403 EXOCYTOSIS 126 310 1.356e-06 1.565e-05
404 REGULATION OF PROTEIN LOCALIZATION 333 950 1.36e-06 1.566e-05
405 NEGATIVE REGULATION OF CELL GROWTH 77 170 1.368e-06 1.571e-05
406 GLOMERULUS DEVELOPMENT 30 49 1.401e-06 1.602e-05
407 CARDIAC CELL DEVELOPMENT 30 49 1.401e-06 1.602e-05
408 CELL MATRIX ADHESION 58 119 1.54e-06 1.756e-05
409 MESENCHYME MORPHOGENESIS 25 38 1.572e-06 1.788e-05
410 DEVELOPMENTAL MATURATION 85 193 1.67e-06 1.896e-05
411 CELL FATE COMMITMENT 97 227 1.689e-06 1.912e-05
412 CELL JUNCTION ORGANIZATION 82 185 1.852e-06 2.092e-05
413 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 83 188 1.953e-06 2.201e-05
414 DIVALENT INORGANIC CATION TRANSPORT 111 268 1.966e-06 2.21e-05
415 RESPONSE TO EXTRACELLULAR STIMULUS 169 441 2.109e-06 2.365e-05
416 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 50 99 2.148e-06 2.397e-05
417 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 50 99 2.148e-06 2.397e-05
418 REGULATION OF CHEMOTAXIS 80 180 2.161e-06 2.406e-05
419 METANEPHRIC NEPHRON DEVELOPMENT 22 32 2.2e-06 2.443e-05
420 LYMPH VESSEL DEVELOPMENT 16 20 2.218e-06 2.457e-05
421 REGULATION OF PROTEIN IMPORT 81 183 2.283e-06 2.523e-05
422 AMINOGLYCAN BIOSYNTHETIC PROCESS 53 107 2.309e-06 2.546e-05
423 REGULATION OF CELL SIZE 77 172 2.375e-06 2.612e-05
424 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 21 30 2.386e-06 2.618e-05
425 EPITHELIAL CELL DEVELOPMENT 82 186 2.405e-06 2.633e-05
426 SYNAPSE ASSEMBLY 38 69 2.414e-06 2.636e-05
427 REGENERATION 73 161 2.422e-06 2.639e-05
428 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 17 22 2.481e-06 2.697e-05
429 GLIOGENESIS 78 175 2.519e-06 2.732e-05
430 METANEPHROS MORPHOGENESIS 20 28 2.531e-06 2.739e-05
431 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 18 24 2.606e-06 2.814e-05
432 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 54 110 2.641e-06 2.844e-05
433 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 93 218 2.976e-06 3.198e-05
434 OVULATION CYCLE 55 113 2.996e-06 3.212e-05
435 ENDOTHELIAL CELL DIFFERENTIATION 39 72 3.097e-06 3.307e-05
436 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 156 404 3.099e-06 3.307e-05
437 REGULATION OF BMP SIGNALING PATHWAY 41 77 3.123e-06 3.321e-05
438 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 50 100 3.126e-06 3.321e-05
439 REGULATION OF MITOTIC CELL CYCLE 177 468 3.184e-06 3.374e-05
440 REGULATION OF PHOSPHOLIPASE C ACTIVITY 25 39 3.205e-06 3.382e-05
441 REGULATION OF AXON GUIDANCE 25 39 3.205e-06 3.382e-05
442 CELL CYCLE ARREST 70 154 3.465e-06 3.647e-05
443 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 51 103 3.605e-06 3.787e-05
444 REGULATION OF PROTEIN BINDING 75 168 3.62e-06 3.794e-05
445 WNT SIGNALING PATHWAY 138 351 3.752e-06 3.923e-05
446 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 42 80 3.845e-06 4.012e-05
447 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 40 75 3.891e-06 4.051e-05
448 PROTEIN HOMOOLIGOMERIZATION 103 248 3.905e-06 4.055e-05
449 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 13 15 4.021e-06 4.167e-05
450 VASCULAR PROCESS IN CIRCULATORY SYSTEM 73 163 4.212e-06 4.355e-05
451 INTRINSIC APOPTOTIC SIGNALING PATHWAY 69 152 4.291e-06 4.427e-05
452 REGULATION OF CELLULAR COMPONENT SIZE 133 337 4.434e-06 4.565e-05
453 AMINOGLYCAN METABOLIC PROCESS 74 166 4.468e-06 4.584e-05
454 RESPONSE TO OXIDATIVE STRESS 138 352 4.473e-06 4.584e-05
455 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 85 197 4.543e-06 4.646e-05
456 REGULATION OF CELL JUNCTION ASSEMBLY 37 68 4.784e-06 4.882e-05
457 GLIAL CELL DIFFERENTIATION 63 136 4.877e-06 4.965e-05
458 RESPONSE TO CAMP 51 104 5.148e-06 5.23e-05
459 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 32 56 5.205e-06 5.277e-05
460 POSITIVE REGULATION OF CELL CYCLE 131 332 5.276e-06 5.337e-05
461 SMALL MOLECULE METABOLIC PROCESS 579 1767 5.425e-06 5.476e-05
462 CARBOHYDRATE DERIVATIVE METABOLIC PROCESS 359 1047 5.497e-06 5.528e-05
463 REGULATION OF ERK1 AND ERK2 CASCADE 99 238 5.501e-06 5.528e-05
464 PLATELET ACTIVATION 65 142 5.708e-06 5.724e-05
465 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 55 115 5.871e-06 5.874e-05
466 REGULATION OF CARDIAC MUSCLE CONTRACTION 36 66 5.944e-06 5.922e-05
467 REGULATION OF CARDIAC CONDUCTION 36 66 5.944e-06 5.922e-05
468 NEGATIVE REGULATION OF KINASE ACTIVITY 103 250 5.96e-06 5.926e-05
469 CELL DIVISION 173 460 6.034e-06 5.986e-05
470 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 70 156 6.049e-06 5.988e-05
471 LEUKOCYTE MIGRATION 106 259 6.267e-06 6.191e-05
472 OSTEOBLAST DIFFERENTIATION 59 126 6.338e-06 6.248e-05
473 RENAL SYSTEM PROCESS 50 102 6.433e-06 6.328e-05
474 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 19 27 6.481e-06 6.349e-05
475 NEGATIVE REGULATION OF AXON GUIDANCE 19 27 6.481e-06 6.349e-05
476 ACTIVATION OF MAPK ACTIVITY 63 137 6.563e-06 6.415e-05
477 REGULATION OF STRIATED MUSCLE CONTRACTION 41 79 7.271e-06 7.078e-05
478 REGULATION OF SYNAPSE ASSEMBLY 41 79 7.271e-06 7.078e-05
479 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 85 199 7.323e-06 7.114e-05
480 REGULATION OF WNT SIGNALING PATHWAY 123 310 7.365e-06 7.14e-05
481 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 24 38 7.381e-06 7.14e-05
482 RESPONSE TO CARBOHYDRATE 74 168 7.565e-06 7.303e-05
483 INNER EAR MORPHOGENESIS 46 92 7.636e-06 7.357e-05
484 ADULT BEHAVIOR 62 135 8.146e-06 7.831e-05
485 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 82 191 8.343e-06 8.005e-05
486 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 36 67 9.374e-06 8.956e-05
487 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 36 67 9.374e-06 8.956e-05
488 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 22 34 1.006e-05 9.529e-05
489 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 22 34 1.006e-05 9.529e-05
490 HEART VALVE DEVELOPMENT 22 34 1.006e-05 9.529e-05
491 NEGATIVE REGULATION OF ORGANELLE ORGANIZATION 148 387 1.002e-05 9.529e-05
492 MYELOID CELL DIFFERENTIATION 81 189 1.021e-05 9.656e-05
493 REGULATION OF NEURON APOPTOTIC PROCESS 82 192 1.057e-05 9.981e-05
494 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 31 55 1.071e-05 0.0001008
495 ACTIN FILAMENT BASED MOVEMENT 46 93 1.101e-05 0.0001032
496 POSITIVE REGULATION OF BLOOD CIRCULATION 46 93 1.101e-05 0.0001032
497 REGULATION OF EXTENT OF CELL GROWTH 49 101 1.137e-05 0.0001062
498 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 39 75 1.136e-05 0.0001062
499 REGULATION OF ACTIN FILAMENT BASED MOVEMENT 21 32 1.158e-05 0.000108
500 REGULATION OF COAGULATION 44 88 1.195e-05 0.0001112
501 MITOTIC CELL CYCLE 269 766 1.202e-05 0.0001116
502 METANEPHRIC MESENCHYME DEVELOPMENT 12 14 1.244e-05 0.0001153
503 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 69 156 1.276e-05 0.000118
504 NEURON PROJECTION EXTENSION 30 53 1.321e-05 0.0001217
505 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 30 53 1.321e-05 0.0001217
506 RESPONSE TO CORTICOSTEROID 76 176 1.368e-05 0.0001258
507 ENSHEATHMENT OF NEURONS 45 91 1.377e-05 0.0001261
508 AXON ENSHEATHMENT 45 91 1.377e-05 0.0001261
509 REGULATION OF MUSCLE ADAPTATION 34 63 1.454e-05 0.000133
510 PROTEIN LOCALIZATION 586 1805 1.589e-05 0.000145
511 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 41 81 1.605e-05 0.0001462
512 REGULATION OF NEURON DEATH 102 252 1.618e-05 0.000147
513 NEURAL CREST CELL MIGRATION 29 51 1.629e-05 0.0001475
514 NEGATIVE REGULATION OF CHEMOTAXIS 29 51 1.629e-05 0.0001475
515 EPITHELIAL TO MESENCHYMAL TRANSITION 31 56 1.753e-05 0.000158
516 OUTFLOW TRACT MORPHOGENESIS 31 56 1.753e-05 0.000158
517 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 61 135 1.79e-05 0.0001611
518 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 35 66 1.815e-05 0.0001621
519 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 35 66 1.815e-05 0.0001621
520 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 33 61 1.811e-05 0.0001621
521 POSITIVE REGULATION OF STEM CELL PROLIFERATION 33 61 1.811e-05 0.0001621
522 POSITIVE REGULATION OF GROWTH 97 238 1.854e-05 0.0001653
523 METANEPHRIC EPITHELIUM DEVELOPMENT 15 20 1.872e-05 0.0001662
524 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 42 84 1.87e-05 0.0001662
525 MUCOPOLYSACCHARIDE METABOLIC PROCESS 51 108 1.961e-05 0.0001738
526 SINGLE ORGANISM CATABOLIC PROCESS 327 957 1.984e-05 0.0001755
527 LEUKOCYTE DIFFERENTIATION 115 292 2.121e-05 0.0001873
528 CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 38 74 2.129e-05 0.0001876
529 CARDIAC CHAMBER DEVELOPMENT 64 144 2.148e-05 0.0001886
530 RESPONSE TO CYTOKINE 251 714 2.149e-05 0.0001886
531 EMBRYONIC EYE MORPHOGENESIS 21 33 2.338e-05 0.0002049
532 REGULATION OF EMBRYONIC DEVELOPMENT 53 114 2.353e-05 0.0002058
533 CELLULAR RESPONSE TO ABIOTIC STIMULUS 105 263 2.44e-05 0.000213
534 SYNAPTIC VESICLE CYCLE 44 90 2.455e-05 0.0002135
535 ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 44 90 2.455e-05 0.0002135
536 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 89 216 2.461e-05 0.0002136
537 PALLIUM DEVELOPMENT 67 153 2.506e-05 0.0002172
538 REGULATION OF SODIUM ION TRANSPORT 39 77 2.515e-05 0.0002175
539 REGULATION OF RECEPTOR ACTIVITY 54 117 2.556e-05 0.0002207
540 POSITIVE REGULATION OF CELL MATRIX ADHESION 24 40 2.577e-05 0.0002216
541 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 24 40 2.577e-05 0.0002216
542 SIGNAL RELEASE 74 173 2.608e-05 0.0002239
543 REGULATION OF MICROTUBULE BASED PROCESS 98 243 2.788e-05 0.0002389
544 CYCLIC NUCLEOTIDE METABOLIC PROCESS 31 57 2.809e-05 0.0002402
545 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 70 162 2.856e-05 0.0002438
546 PEPTIDYL SERINE MODIFICATION 65 148 2.94e-05 0.0002497
547 ADULT LOCOMOTORY BEHAVIOR 40 80 2.931e-05 0.0002497
548 DIGESTIVE SYSTEM DEVELOPMENT 65 148 2.94e-05 0.0002497
549 RESPONSE TO ALKALOID 61 137 3.096e-05 0.0002619
550 SKELETAL MUSCLE ORGAN DEVELOPMENT 61 137 3.096e-05 0.0002619
551 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 23 38 3.114e-05 0.0002629
552 CARDIAC MUSCLE CELL CONTRACTION 19 29 3.16e-05 0.0002664
553 REGULATION OF ADHERENS JUNCTION ORGANIZATION 28 50 3.337e-05 0.0002798
554 FACE DEVELOPMENT 28 50 3.337e-05 0.0002798
555 RESPONSE TO PROGESTERONE 28 50 3.337e-05 0.0002798
556 REGULATION OF LIPASE ACTIVITY 41 83 3.374e-05 0.0002824
557 CELL JUNCTION ASSEMBLY 58 129 3.397e-05 0.0002838
558 RESPONSE TO LIGHT STIMULUS 110 280 3.582e-05 0.0002987
559 NEURON MIGRATION 51 110 3.643e-05 0.0003032
560 REGULATION OF PROTEIN KINASE B SIGNALING 55 121 3.687e-05 0.0003063
561 REGULATION OF EXOCYTOSIS 78 186 3.7e-05 0.0003069
562 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 25 43 3.721e-05 0.000308
563 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 22 36 3.748e-05 0.0003092
564 HEAD MORPHOGENESIS 22 36 3.748e-05 0.0003092
565 VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION 11 13 3.806e-05 0.0003134
566 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 42 86 3.842e-05 0.0003159
567 INOSITOL LIPID MEDIATED SIGNALING 56 124 3.945e-05 0.0003237
568 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 73 172 4.029e-05 0.00033
569 PLACENTA DEVELOPMENT 61 138 4.036e-05 0.0003301
570 ORGANIC ANION TRANSPORT 145 387 4.081e-05 0.0003331
571 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 285 829 4.089e-05 0.0003332
572 CALCIUM ION REGULATED EXOCYTOSIS 40 81 4.224e-05 0.0003436
573 REGULATION OF CARTILAGE DEVELOPMENT 33 63 4.342e-05 0.0003526
574 REGULATION OF REGULATED SECRETORY PATHWAY 58 130 4.463e-05 0.0003618
575 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 252 724 4.474e-05 0.0003621
576 POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 16 23 4.492e-05 0.0003622
577 CAMP METABOLIC PROCESS 21 34 4.492e-05 0.0003622
578 PROTEIN OLIGOMERIZATION 160 434 4.525e-05 0.0003643
579 REGULATION OF MEMBRANE DEPOLARIZATION 24 41 4.556e-05 0.0003655
580 AORTA DEVELOPMENT 24 41 4.556e-05 0.0003655
581 GLIAL CELL DEVELOPMENT 38 76 4.596e-05 0.0003681
582 METANEPHRIC NEPHRON MORPHOGENESIS 15 21 4.836e-05 0.000386
583 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 15 21 4.836e-05 0.000386
584 EYE MORPHOGENESIS 60 136 4.978e-05 0.0003966
585 ORGANIC ACID TRANSPORT 103 261 5.044e-05 0.0004012
586 POSITIVE REGULATION OF LIPASE ACTIVITY 34 66 5.23e-05 0.0004152
587 BONE DEVELOPMENT 67 156 5.264e-05 0.0004166
588 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 67 156 5.264e-05 0.0004166
589 DENDRITE DEVELOPMENT 39 79 5.289e-05 0.0004178
590 ENDOCARDIAL CUSHION DEVELOPMENT 20 32 5.354e-05 0.0004222
591 CELLULAR RESPONSE TO FATTY ACID 28 51 5.416e-05 0.0004264
592 LONG TERM SYNAPTIC POTENTIATION 23 39 5.568e-05 0.0004362
593 COCHLEA DEVELOPMENT 23 39 5.568e-05 0.0004362
594 NEGATIVE CHEMOTAXIS 23 39 5.568e-05 0.0004362
595 SYNAPTIC VESICLE LOCALIZATION 49 106 5.639e-05 0.0004407
596 CELL CHEMOTAXIS 69 162 5.644e-05 0.0004407
597 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 53 117 5.67e-05 0.0004412
598 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 53 117 5.67e-05 0.0004412
599 RESPONSE TO REACTIVE OXYGEN SPECIES 79 191 5.846e-05 0.0004541
600 POSITIVE REGULATION OF CELL CYCLE PROCESS 98 247 5.94e-05 0.0004607
601 RECEPTOR METABOLIC PROCESS 40 82 6.017e-05 0.0004658
602 RESPONSE TO HYDROGEN PEROXIDE 50 109 6.1e-05 0.0004715
603 BODY MORPHOGENESIS 25 44 6.316e-05 0.0004873
604 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 19 30 6.339e-05 0.0004884
605 SMALL MOLECULE BIOSYNTHETIC PROCESS 162 443 6.597e-05 0.0005074
606 HEART PROCESS 41 85 6.776e-05 0.0005202
607 REGULATION OF MUSCLE HYPERTROPHY 22 37 6.788e-05 0.0005203
608 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 56 126 6.816e-05 0.0005216
609 CARDIAC CHAMBER MORPHOGENESIS 48 104 7.017e-05 0.0005361
610 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 62 143 7.044e-05 0.0005373
611 CELLULAR RESPONSE TO BIOTIC STIMULUS 69 163 7.117e-05 0.000542
612 PURINE CONTAINING COMPOUND METABOLIC PROCESS 146 394 7.174e-05 0.0005454
613 MUSCLE HYPERTROPHY 18 28 7.446e-05 0.0005652
614 LYMPHOCYTE ACTIVATION 129 342 7.464e-05 0.0005657
615 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 86 213 7.951e-05 0.0006016
616 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 46 99 8.044e-05 0.0006076
617 REGULATION OF TISSUE REMODELING 32 62 8.209e-05 0.0006181
618 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 32 62 8.209e-05 0.0006181
619 POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 37 75 8.299e-05 0.0006238
620 CELLULAR RESPONSE TO OXIDATIVE STRESS 76 184 8.43e-05 0.0006327
621 PROTEOGLYCAN METABOLIC PROCESS 40 83 8.476e-05 0.000634
622 REGULATION OF POTASSIUM ION TRANSPORT 40 83 8.476e-05 0.000634
623 DEVELOPMENTAL PROGRAMMED CELL DEATH 17 26 8.659e-05 0.0006457
624 REGULATION OF MESONEPHROS DEVELOPMENT 17 26 8.659e-05 0.0006457
625 ORGANOPHOSPHATE CATABOLIC PROCESS 51 113 8.715e-05 0.0006488
626 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 78 190 8.737e-05 0.0006494
627 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 62 144 9.001e-05 0.000668
628 NEGATIVE REGULATION OF AXONOGENESIS 33 65 9.728e-05 0.0007208
629 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 16 24 9.942e-05 0.0007354
630 PROTEIN MATURATION 103 265 0.0001017 0.0007513
631 REGULATION OF SMOOTH MUSCLE CONTRACTION 31 60 0.0001029 0.0007563
632 CHONDROCYTE DIFFERENTIATION 31 60 0.0001029 0.0007563
633 OLIGODENDROCYTE DIFFERENTIATION 31 60 0.0001029 0.0007563
634 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 25 45 0.0001042 0.0007647
635 EPITHELIAL CELL PROLIFERATION 42 89 0.0001044 0.0007653
636 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 27 50 0.0001073 0.0007828
637 RESPONSE TO GAMMA RADIATION 27 50 0.0001073 0.0007828
638 RESPONSE TO NUTRIENT 78 191 0.0001073 0.0007828
639 NEGATIVE REGULATION OF SECRETION 81 200 0.0001116 0.0008128
640 NEGATIVE REGULATION OF MUSCLE CONTRACTION 15 22 0.0001123 0.0008137
641 ENDOCARDIAL CUSHION MORPHOGENESIS 15 22 0.0001123 0.0008137
642 CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION 15 22 0.0001123 0.0008137
643 VESICLE MEDIATED TRANSPORT 407 1239 0.0001139 0.0008239
644 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 10 12 0.0001151 0.0008313
645 NEGATIVE REGULATION OF NEURON DEATH 71 171 0.0001169 0.0008431
646 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 40 84 0.0001181 0.0008494
647 CYTOKINESIS 40 84 0.0001181 0.0008494
648 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 57 131 0.0001202 0.0008604
649 CELL MATURATION 57 131 0.0001202 0.0008604
650 RETINA DEVELOPMENT IN CAMERA TYPE EYE 57 131 0.0001202 0.0008604
651 INTERACTION WITH HOST 58 134 0.0001254 0.0008961
652 PROTEOGLYCAN BIOSYNTHETIC PROCESS 30 58 0.000129 0.0009206
653 CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 11 14 0.000132 0.0009391
654 CAMP CATABOLIC PROCESS 11 14 0.000132 0.0009391
655 POTASSIUM ION HOMEOSTASIS 13 18 0.000133 0.0009408
656 SMOOTH MUSCLE TISSUE DEVELOPMENT 13 18 0.000133 0.0009408
657 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 13 18 0.000133 0.0009408
658 KIDNEY MESENCHYME DEVELOPMENT 13 18 0.000133 0.0009408
659 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 26 48 0.000134 0.0009449
660 RESPONSE TO AXON INJURY 26 48 0.000134 0.0009449
661 REGULATION OF CELL CELL ADHESION 140 380 0.0001354 0.000953
662 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 12 16 0.0001368 0.0009614
663 RESPONSE TO AMINO ACID 50 112 0.0001422 0.0009969
664 REGULATION OF VASOCONSTRICTION 33 66 0.0001423 0.0009969
665 CALCIUM MEDIATED SIGNALING 42 90 0.0001429 0.0009998
666 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 71 172 0.0001447 0.001011
667 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 56 129 0.0001478 0.001031
668 ACTIN MEDIATED CELL CONTRACTION 36 74 0.000148 0.001031
669 CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS 208 595 0.0001517 0.001055
670 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 31 61 0.0001531 0.001063
671 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 64 152 0.0001535 0.001064
672 POSITIVE REGULATION OF CELL DIVISION 57 132 0.000154 0.001067
673 SENSORY PERCEPTION OF MECHANICAL STIMULUS 65 155 0.0001576 0.001089
674 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 58 135 0.00016 0.001105
675 CARDIAC SEPTUM DEVELOPMENT 40 85 0.0001629 0.00112
676 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 40 85 0.0001629 0.00112
677 NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS 34 69 0.0001635 0.00112
678 NEGATIVE REGULATION OF OSSIFICATION 34 69 0.0001635 0.00112
679 POSITIVE REGULATION OF AXONOGENESIS 34 69 0.0001635 0.00112
680 RESPONSE TO INSULIN 82 205 0.0001661 0.001135
681 PLATELET DEGRANULATION 48 107 0.0001659 0.001135
682 POSITIVE REGULATION OF PROTEIN SECRETION 84 211 0.0001682 0.001146
683 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 84 211 0.0001682 0.001146
684 ACTIVATION OF PHOSPHOLIPASE C ACTIVITY 17 27 0.0001724 0.001173
685 AMINO ACID TRANSPORT 54 124 0.0001742 0.001183
686 LUNG EPITHELIUM DEVELOPMENT 20 34 0.0001785 0.001207
687 RESPONSE TO FLUID SHEAR STRESS 20 34 0.0001785 0.001207
688 REGULATION OF MESENCHYMAL CELL PROLIFERATION 20 34 0.0001785 0.001207
689 POSITIVE REGULATION OF BINDING 55 127 0.0001818 0.001228
690 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 30 59 0.0001921 0.001296
691 ORGAN REGENERATION 39 83 0.0002034 0.00137
692 LUNG CELL DIFFERENTIATION 16 25 0.0002038 0.001371
693 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 92 236 0.0002049 0.001376
694 CEREBRAL CORTEX DEVELOPMENT 47 105 0.0002055 0.001378
695 REGULATION OF NEURONAL SYNAPTIC PLASTICITY 26 49 0.0002094 0.00139
696 SENSORY PERCEPTION OF PAIN 36 75 0.000208 0.00139
697 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 26 49 0.0002094 0.00139
698 RESPONSE TO BMP 43 94 0.0002091 0.00139
699 CELLULAR GLUCOSE HOMEOSTASIS 36 75 0.000208 0.00139
700 CARDIAC SEPTUM MORPHOGENESIS 26 49 0.0002094 0.00139
701 CELLULAR RESPONSE TO BMP STIMULUS 43 94 0.0002091 0.00139
702 PROTEIN COMPLEX SUBUNIT ORGANIZATION 491 1527 0.0002168 0.001437
703 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 19 32 0.0002184 0.001446
704 CELL CYCLE G1 S PHASE TRANSITION 49 111 0.0002297 0.001516
705 G1 S TRANSITION OF MITOTIC CELL CYCLE 49 111 0.0002297 0.001516
706 REGULATION OF OSTEOBLAST PROLIFERATION 15 23 0.0002386 0.00157
707 LEUKOCYTE CELL CELL ADHESION 98 255 0.0002385 0.00157
708 ENDOTHELIAL CELL MIGRATION 29 57 0.0002412 0.001584
709 NOTCH SIGNALING PATHWAY 50 114 0.0002414 0.001584
710 RECEPTOR MEDIATED ENDOCYTOSIS 90 231 0.0002441 0.001599
711 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 136 372 0.0002463 0.001612
712 HINDLIMB MORPHOGENESIS 21 37 0.0002474 0.001613
713 ORGANIC ACID METABOLIC PROCESS 317 953 0.0002475 0.001613
714 AXON EXTENSION 21 37 0.0002474 0.001613
715 HIPPOCAMPUS DEVELOPMENT 35 73 0.0002604 0.001695
716 DENDRITE MORPHOGENESIS 23 42 0.000261 0.001696
717 INFLAMMATORY RESPONSE 162 454 0.0002638 0.001712
718 MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 18 30 0.0002664 0.001727
719 REGULATION OF GLUCOSE METABOLIC PROCESS 47 106 0.0002693 0.001741
720 FAT CELL DIFFERENTIATION 47 106 0.0002693 0.001741
721 POSITIVE REGULATION OF MITOTIC CELL CYCLE 53 123 0.0002746 0.001772
722 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 14 21 0.0002754 0.001773
723 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 14 21 0.0002754 0.001773
724 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 39 84 0.0002773 0.00178
725 TISSUE MIGRATION 39 84 0.0002773 0.00178
726 CELLULAR RESPONSE TO INSULIN STIMULUS 61 146 0.000278 0.001782
727 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 30 60 0.0002814 0.001798
728 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 30 60 0.0002814 0.001798
729 REGULATION OF CALCIUM MEDIATED SIGNALING 36 76 0.0002888 0.001843
730 ORGAN GROWTH 33 68 0.0002914 0.001858
731 LEUKOCYTE ACTIVATION 149 414 0.000294 0.001871
732 REGULATION OF REPRODUCTIVE PROCESS 55 129 0.0002949 0.001875
733 RESPONSE TO VITAMIN 44 98 0.0002972 0.001887
734 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 40 87 0.0003005 0.001905
735 ENDOCYTOSIS 179 509 0.0003025 0.001915
736 RESPONSE TO CALCIUM ION 50 115 0.0003113 0.001968
737 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 13 19 0.0003123 0.001969
738 ATRIOVENTRICULAR VALVE DEVELOPMENT 13 19 0.0003123 0.001969
739 REGULATION OF CELL DIVISION 103 272 0.0003176 0.002
740 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 26 50 0.0003199 0.002002
741 GLUCOSE HOMEOSTASIS 69 170 0.0003202 0.002002
742 RECEPTOR INTERNALIZATION 26 50 0.0003199 0.002002
743 CARBOHYDRATE HOMEOSTASIS 69 170 0.0003202 0.002002
744 RHO PROTEIN SIGNAL TRANSDUCTION 26 50 0.0003199 0.002002
745 REGULATION OF ANION TRANSPORT 58 138 0.0003224 0.002013
746 VENTRICULAR SEPTUM MORPHOGENESIS 17 28 0.0003237 0.002014
747 RIBONUCLEOTIDE CATABOLIC PROCESS 17 28 0.0003237 0.002014
748 LONG TERM MEMORY 17 28 0.0003237 0.002014
749 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 22 40 0.0003259 0.002021
750 FORELIMB MORPHOGENESIS 22 40 0.0003259 0.002021
751 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 34 71 0.0003262 0.002021
752 ANION TRANSMEMBRANE TRANSPORT 96 251 0.0003336 0.002064
753 SODIUM ION TRANSPORT 60 144 0.0003386 0.002092
754 SULFUR COMPOUND BIOSYNTHETIC PROCESS 80 203 0.0003453 0.002128
755 CYCLIC NUCLEOTIDE CATABOLIC PROCESS 12 17 0.0003453 0.002128
756 NEGATIVE REGULATION OF WOUND HEALING 29 58 0.0003535 0.002176
757 REGULATION OF LIPID METABOLIC PROCESS 106 282 0.0003601 0.002213
758 SOMATIC STEM CELL POPULATION MAINTENANCE 32 66 0.0003655 0.002244
759 MYELOID LEUKOCYTE DIFFERENTIATION 43 96 0.0003686 0.002254
760 REGULATION OF N METHYL D ASPARTATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY 11 15 0.0003682 0.002254
761 NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 11 15 0.0003682 0.002254
762 RELAXATION OF CARDIAC MUSCLE 10 13 0.0003717 0.002258
763 POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS 10 13 0.0003717 0.002258
764 PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION 10 13 0.0003717 0.002258
765 PERIPHERAL NERVOUS SYSTEM NEURON DEVELOPMENT 10 13 0.0003717 0.002258
766 LYMPH VESSEL MORPHOGENESIS 10 13 0.0003717 0.002258
767 NEURON RECOGNITION 19 33 0.0003792 0.002301
768 MAMMARY GLAND EPITHELIUM DEVELOPMENT 27 53 0.0003808 0.002301
769 CYTOSOLIC CALCIUM ION TRANSPORT 27 53 0.0003808 0.002301
770 SKELETAL MUSCLE CELL DIFFERENTIATION 27 53 0.0003808 0.002301
771 HEART GROWTH 16 26 0.0003915 0.002362
772 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 25 48 0.0004019 0.002419
773 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 25 48 0.0004019 0.002419
774 OVULATION CYCLE PROCESS 40 88 0.0004024 0.002419
775 REGULATION OF CELL SHAPE 58 139 0.000403 0.002419
776 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 30 61 0.0004055 0.002432
777 COLLAGEN FIBRIL ORGANIZATION 21 38 0.0004069 0.002433
778 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 21 38 0.0004069 0.002433
779 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 33 69 0.0004087 0.002441
780 MALE SEX DIFFERENTIATION 61 148 0.0004287 0.002557
781 STEROID HORMONE MEDIATED SIGNALING PATHWAY 53 125 0.0004423 0.002635
782 POSITIVE REGULATION OF PEPTIDASE ACTIVITY 63 154 0.0004432 0.002637
783 SMAD PROTEIN SIGNAL TRANSDUCTION 28 56 0.0004443 0.00264
784 ORGANOPHOSPHATE METABOLIC PROCESS 294 885 0.0004498 0.002669
785 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 54 128 0.0004554 0.002699
786 REGULATION OF PROTEIN ACETYLATION 31 64 0.0004586 0.002715
787 EMBRYONIC PLACENTA DEVELOPMENT 38 83 0.0004664 0.002757
788 REGULATION OF SYNAPTIC VESICLE TRANSPORT 18 31 0.0004684 0.002766
789 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 15 24 0.0004705 0.002775
790 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 48 111 0.0004718 0.002779
791 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 70 175 0.0004782 0.002813
792 HOMOTYPIC CELL CELL ADHESION 26 51 0.0004788 0.002813
793 POSITIVE REGULATION OF ENDOCYTOSIS 49 114 0.0004904 0.002877
794 REGULATION OF CELLULAR PROTEIN LOCALIZATION 191 552 0.0004996 0.002928
795 REGULATION OF CHONDROCYTE DIFFERENTIATION 24 46 0.000505 0.002956
796 MITOTIC DNA INTEGRITY CHECKPOINT 44 100 0.000509 0.002968
797 SEMAPHORIN PLEXIN SIGNALING PATHWAY 20 36 0.0005078 0.002968
798 LIMBIC SYSTEM DEVELOPMENT 44 100 0.000509 0.002968
799 RAS PROTEIN SIGNAL TRANSDUCTION 59 143 0.000511 0.002976
800 SULFUR COMPOUND METABOLIC PROCESS 130 359 0.0005202 0.003025
801 REGULATION OF CALCIUM ION IMPORT 45 103 0.0005338 0.003098
802 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 40 89 0.000534 0.003098
803 SEX DETERMINATION 14 22 0.000561 0.003235
804 MONOSACCHARIDE BIOSYNTHETIC PROCESS 27 54 0.0005587 0.003235
805 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 14 22 0.000561 0.003235
806 ACTIVATION OF PROTEIN KINASE B ACTIVITY 14 22 0.000561 0.003235
807 AORTA MORPHOGENESIS 14 22 0.000561 0.003235
808 RESPONSE TO ISCHEMIA 17 29 0.0005775 0.003317
809 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 17 29 0.0005775 0.003317
810 NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION 85 221 0.0005762 0.003317
811 REGULATION OF JUN KINASE ACTIVITY 37 81 0.000581 0.003333
812 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 81 209 0.0005843 0.003348
813 CARBOXYLIC ACID BIOSYNTHETIC PROCESS 101 270 0.0005929 0.003389
814 ORGANIC ACID BIOSYNTHETIC PROCESS 101 270 0.0005929 0.003389
815 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 42 95 0.0005984 0.003416
816 CELLULAR RESPONSE TO CALCIUM ION 25 49 0.0006024 0.003435
817 POSITIVE REGULATION OF PROTEIN BINDING 34 73 0.0006193 0.003519
818 ASSOCIATIVE LEARNING 34 73 0.0006193 0.003519
819 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 34 73 0.0006193 0.003519
820 MEMORY 43 98 0.000629 0.003561
821 NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS 185 535 0.0006279 0.003561
822 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 43 98 0.000629 0.003561
823 LABYRINTHINE LAYER DEVELOPMENT 23 44 0.000635 0.00359
824 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 60 147 0.0006402 0.003615
825 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 50 118 0.0006431 0.003627
826 CELLULAR RESPONSE TO NUTRIENT 21 39 0.0006487 0.003654
827 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 39 87 0.0006631 0.003682
828 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 39 87 0.0006631 0.003682
829 VIRAL ENTRY INTO HOST CELL 39 87 0.0006631 0.003682
830 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 39 87 0.0006631 0.003682
831 RELAXATION OF MUSCLE 13 20 0.0006619 0.003682
832 PARTURITION 13 20 0.0006619 0.003682
833 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 51 121 0.0006619 0.003682
834 MOVEMENT IN HOST ENVIRONMENT 39 87 0.0006631 0.003682
835 ENTRY INTO HOST 39 87 0.0006631 0.003682
836 CAMERA TYPE EYE MORPHOGENESIS 44 101 0.0006585 0.003682
837 AXONAL FASCICULATION 13 20 0.0006619 0.003682
838 ENTRY INTO HOST CELL 39 87 0.0006631 0.003682
839 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 35 76 0.000672 0.003714
840 REGULATION OF JNK CASCADE 64 159 0.0006706 0.003714
841 EXTRACELLULAR MATRIX DISASSEMBLY 35 76 0.000672 0.003714
842 CALCIUM ION TRANSMEMBRANE TRANSPORT 64 159 0.0006706 0.003714
843 PEPTIDYL AMINO ACID MODIFICATION 279 841 0.0006823 0.003766
844 SODIUM ION TRANSMEMBRANE TRANSPORT 40 90 0.0007024 0.003872
845 MOTOR NEURON AXON GUIDANCE 16 27 0.0007101 0.003901
846 REGULATION OF CATENIN IMPORT INTO NUCLEUS 16 27 0.0007101 0.003901
847 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 16 27 0.0007101 0.003901
848 REGULATION OF PROTEOLYSIS 239 711 0.000722 0.003962
849 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 36 79 0.0007237 0.003966
850 MULTI ORGANISM REPRODUCTIVE PROCESS 294 891 0.0007244 0.003966
851 MULTICELLULAR ORGANISM METABOLIC PROCESS 41 93 0.0007404 0.004048
852 MITOTIC CELL CYCLE CHECKPOINT 57 139 0.0007526 0.00411
853 RESPONSE TO CAFFEINE 12 18 0.0007698 0.004194
854 INOSITOL PHOSPHATE MEDIATED SIGNALING 12 18 0.0007698 0.004194
855 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 33 71 0.0007741 0.004207
856 NEGATIVE REGULATION OF MAPK CASCADE 59 145 0.0007748 0.004207
857 REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 59 145 0.0007748 0.004207
858 RESPONSE TO TEMPERATURE STIMULUS 60 148 0.0007844 0.004254
859 REGULATION OF CYTOKINE PRODUCTION 193 563 0.0007897 0.004274
860 SALIVARY GLAND DEVELOPMENT 18 32 0.0007899 0.004274
861 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 22 42 0.0007989 0.004302
862 REGULATION OF BONE REMODELING 22 42 0.0007989 0.004302
863 REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS 22 42 0.0007989 0.004302
864 REGULATION OF CARBOHYDRATE CATABOLIC PROCESS 22 42 0.0007989 0.004302
865 CRANIAL SKELETAL SYSTEM DEVELOPMENT 27 55 0.0008052 0.004327
866 RESPONSE TO OSMOTIC STRESS 30 63 0.0008054 0.004327
867 CORONARY VASCULATURE DEVELOPMENT 20 37 0.000814 0.004354
868 REGULATION OF MEMBRANE LIPID DISTRIBUTION 20 37 0.000814 0.004354
869 STRIATED MUSCLE CONTRACTION 43 99 0.0008121 0.004354
870 IMPORT INTO CELL 20 37 0.000814 0.004354
871 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 66 166 0.0008238 0.004401
872 PROTEIN DEPHOSPHORYLATION 74 190 0.0008351 0.004456
873 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 72 184 0.000836 0.004456
874 CELL CELL JUNCTION ASSEMBLY 34 74 0.0008386 0.004465
875 POSITIVE REGULATION OF PROTEOLYSIS 130 363 0.0008581 0.004563
876 LENS FIBER CELL DIFFERENTIATION 15 25 0.0008704 0.004597
877 HEPATICOBILIARY SYSTEM DEVELOPMENT 53 128 0.0008666 0.004597
878 EPITHELIAL CELL APOPTOTIC PROCESS 15 25 0.0008704 0.004597
879 HISTONE PHOSPHORYLATION 15 25 0.0008704 0.004597
880 REGULATION OF CATION CHANNEL ACTIVITY 39 88 0.0008705 0.004597
881 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 15 25 0.0008704 0.004597
882 NEGATIVE REGULATION OF CATECHOLAMINE SECRETION 11 16 0.0008774 0.004618
883 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 11 16 0.0008774 0.004618
884 ATRIOVENTRICULAR VALVE MORPHOGENESIS 11 16 0.0008774 0.004618
885 REGULATION OF ORGANIC ACID TRANSPORT 25 50 0.0008849 0.004642
886 REGULATION OF COENZYME METABOLIC PROCESS 25 50 0.0008849 0.004642
887 REGULATION OF COFACTOR METABOLIC PROCESS 25 50 0.0008849 0.004642
888 REGULATION OF CELL ACTIVATION 168 484 0.0008962 0.004696
889 PROTEIN LOCALIZATION TO MEMBRANE 134 376 0.0009006 0.004713
890 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 35 77 0.0009016 0.004713
891 POSITIVE REGULATION OF ANION TRANSPORT 28 58 0.000908 0.004742
892 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 126 351 0.000921 0.004804
893 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 59 146 0.0009475 0.004937
894 SMOOTH MUSCLE CONTRACTION 23 45 0.0009551 0.004965
895 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 23 45 0.0009551 0.004965
896 CELLULAR RESPONSE TO MECHANICAL STIMULUS 36 80 0.0009627 0.004999
897 POSITIVE REGULATION OF P38MAPK CASCADE 10 14 0.0009711 0.005015
898 T CELL MIGRATION 10 14 0.0009711 0.005015
899 POSITIVE REGULATION OF AMINO ACID TRANSPORT 10 14 0.0009711 0.005015
900 POST EMBRYONIC ORGAN DEVELOPMENT 10 14 0.0009711 0.005015
901 REGULATION OF HISTONE H3 K9 ACETYLATION 10 14 0.0009711 0.005015
902 REGULATION OF CELL PROJECTION ASSEMBLY 62 155 0.0009724 0.005016
903 NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 17 30 0.0009842 0.005049
904 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 17 30 0.0009842 0.005049
905 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 77 200 0.0009817 0.005049
906 ESTABLISHMENT OF ENDOTHELIAL BARRIER 17 30 0.0009842 0.005049
907 REGULATION OF MEMBRANE REPOLARIZATION 17 30 0.0009842 0.005049
908 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 42 97 0.001001 0.005131
909 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 21 40 0.001006 0.005147
910 CELLULAR RESPONSE TO AMINO ACID STIMULUS 26 53 0.001013 0.00518
911 NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 19 35 0.001022 0.005207
912 NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 19 35 0.001022 0.005207
913 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 19 35 0.001022 0.005207
914 CELLULAR POTASSIUM ION HOMEOSTASIS 9 12 0.001027 0.005226
915 MONOVALENT INORGANIC CATION HOMEOSTASIS 51 123 0.001034 0.005257
916 MEMBRANE ORGANIZATION 295 899 0.001038 0.005274
917 REGULATION OF AMINE TRANSPORT 33 72 0.001047 0.005311
918 RESPONSE TO AUDITORY STIMULUS 14 23 0.001063 0.005386
919 ORGANONITROGEN COMPOUND METABOLIC PROCESS 563 1796 0.001075 0.005445
920 ORGANIC ACID TRANSMEMBRANE TRANSPORT 44 103 0.001078 0.005453
921 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 130 365 0.001092 0.005519
922 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 45 106 0.001114 0.005589
923 REGULATION OF FAT CELL DIFFERENTIATION 45 106 0.001114 0.005589
924 RESPONSE TO GLUCAGON 24 48 0.001115 0.005589
925 REGULATION OF LIPID KINASE ACTIVITY 24 48 0.001115 0.005589
926 REGULATION OF NEUROTRANSMITTER TRANSPORT 30 64 0.001111 0.005589
927 CARDIAC VENTRICLE DEVELOPMENT 45 106 0.001114 0.005589
928 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 24 48 0.001115 0.005589
929 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 81 213 0.001128 0.005651
930 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 22 43 0.001204 0.00601
931 CELL FATE DETERMINATION 22 43 0.001204 0.00601
932 REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 22 43 0.001204 0.00601
933 RESPONSE TO INTERLEUKIN 1 48 115 0.001207 0.006018
934 CELL AGING 31 67 0.00121 0.006029
935 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 41 95 0.001234 0.006134
936 CANONICAL WNT SIGNALING PATHWAY 41 95 0.001234 0.006134
937 REGULATION OF APOPTOTIC SIGNALING PATHWAY 129 363 0.001253 0.006222
938 NEGATIVE REGULATION OF AXON EXTENSION 20 38 0.001266 0.006269
939 REGULATION OF ACTION POTENTIAL 20 38 0.001266 0.006269
940 REGULATION OF INFLAMMATORY RESPONSE 107 294 0.001265 0.006269
941 REGULATION OF NEUROTRANSMITTER SECRETION 25 51 0.001275 0.006306
942 RESPONSE TO VITAMIN D 18 33 0.001283 0.006316
943 NEURON PROJECTION REGENERATION 18 33 0.001283 0.006316
944 REGULATION OF BONE RESORPTION 18 33 0.001283 0.006316
945 G2 DNA DAMAGE CHECKPOINT 18 33 0.001283 0.006316
946 CELL AGGREGATION 13 21 0.00129 0.006337
947 CARTILAGE CONDENSATION 13 21 0.00129 0.006337
948 REGULATION OF CATABOLIC PROCESS 243 731 0.001298 0.006372
949 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 32 70 0.001306 0.006405
950 POSITIVE REGULATION OF PROTEIN IMPORT 44 104 0.001365 0.006687
951 REGULATION OF ENDOCYTOSIS 76 199 0.001371 0.006706
952 FOREBRAIN CELL MIGRATION 29 62 0.001392 0.006798
953 EMBRYONIC HEART TUBE MORPHOGENESIS 29 62 0.001392 0.006798
954 EMBRYONIC HEART TUBE DEVELOPMENT 33 73 0.001399 0.00681
955 REGULATION OF PLASMA MEMBRANE ORGANIZATION 33 73 0.001399 0.00681
956 RESPONSE TO TRANSITION METAL NANOPARTICLE 59 148 0.001398 0.00681
957 TISSUE REMODELING 38 87 0.001401 0.006811
958 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 23 46 0.001405 0.006817
959 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 23 46 0.001405 0.006817
960 VENTRICULAR SEPTUM DEVELOPMENT 26 54 0.001435 0.006955
961 CALCIUM ION IMPORT 30 65 0.001513 0.007328
962 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 21 41 0.001518 0.007329
963 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 21 41 0.001518 0.007329
964 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 21 41 0.001518 0.007329
965 POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 15 26 0.001524 0.007331
966 REGULATION OF CELLULAR SENESCENCE 15 26 0.001524 0.007331
967 REGULATION OF P38MAPK CASCADE 15 26 0.001524 0.007331
968 GLUCOSE METABOLIC PROCESS 49 119 0.001531 0.007359
969 CELLULAR RESPONSE TO GAMMA RADIATION 12 19 0.001554 0.007432
970 REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION 12 19 0.001554 0.007432
971 KIDNEY VASCULATURE DEVELOPMENT 12 19 0.001554 0.007432
972 RENAL SYSTEM VASCULATURE DEVELOPMENT 12 19 0.001554 0.007432
973 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 12 19 0.001554 0.007432
974 SINGLE ORGANISM CELLULAR LOCALIZATION 293 898 0.00157 0.007498
975 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 19 36 0.001596 0.007609
976 CORTICAL CYTOSKELETON ORGANIZATION 19 36 0.001596 0.007609
977 CARDIAC ATRIUM DEVELOPMENT 17 31 0.001611 0.007647
978 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 17 31 0.001611 0.007647
979 REGULATION OF PLATELET ACTIVATION 17 31 0.001611 0.007647
980 MATERNAL PLACENTA DEVELOPMENT 17 31 0.001611 0.007647
981 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 75 197 0.001621 0.007687
982 NERVE DEVELOPMENT 31 68 0.00163 0.007725
983 CELL CYCLE CHECKPOINT 74 194 0.001632 0.007725
984 REGULATION OF CELL CYCLE PROCESS 189 558 0.001672 0.007908
985 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 61 155 0.001696 0.008012
986 HORMONE MEDIATED SIGNALING PATHWAY 62 158 0.001698 0.008014
987 STEM CELL PROLIFERATION 28 60 0.001745 0.008227
988 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 25 52 0.001805 0.008485
989 MYELOID CELL HOMEOSTASIS 38 88 0.001804 0.008485
990 POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 25 52 0.001805 0.008485
991 BRANCH ELONGATION OF AN EPITHELIUM 11 17 0.001853 0.008666
992 RESPONSE TO ANGIOTENSIN 11 17 0.001853 0.008666
993 REGULATION OF ENERGY HOMEOSTASIS 11 17 0.001853 0.008666
994 REGULATION OF PLATELET AGGREGATION 11 17 0.001853 0.008666
995 INTESTINAL EPITHELIAL CELL DIFFERENTIATION 11 17 0.001853 0.008666
996 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 14 24 0.001891 0.008783
997 REGULATION OF PEPTIDASE ACTIVITY 137 392 0.001888 0.008783
998 POSITIVE REGULATION OF RECEPTOR INTERNALIZATION 14 24 0.001891 0.008783
999 REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY 14 24 0.001891 0.008783
1000 POSITIVE REGULATION OF CHEMOTAXIS 49 120 0.001889 0.008783
1001 REGULATION OF DENDRITE DEVELOPMENT 49 120 0.001889 0.008783
1002 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 175 514 0.001888 0.008783
1003 PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 20 39 0.001917 0.008874
1004 NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 20 39 0.001917 0.008874
1005 PLATELET AGGREGATION 20 39 0.001917 0.008874
1006 ACTOMYOSIN STRUCTURE ORGANIZATION 34 77 0.001952 0.009029
1007 REGULATION OF CAMP METABOLIC PROCESS 52 129 0.001956 0.00904
1008 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 54 135 0.001988 0.009177
1009 NEUROMUSCULAR PROCESS 41 97 0.001994 0.009196
1010 NEGATIVE REGULATION OF PROTEIN POLYMERIZATION 26 55 0.002 0.009212
1011 REGULATION OF PROTEIN TARGETING 110 307 0.002003 0.009218
1012 RESPONSE TO PROSTAGLANDIN 18 34 0.002013 0.009219
1013 RENAL WATER HOMEOSTASIS 18 34 0.002013 0.009219
1014 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 18 34 0.002013 0.009219
1015 OLIGODENDROCYTE DEVELOPMENT 18 34 0.002013 0.009219
1016 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 66 171 0.002009 0.009219
1017 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 16 29 0.002023 0.009242
1018 POTASSIUM ION IMPORT 16 29 0.002023 0.009242
1019 ORGANELLE LOCALIZATION 144 415 0.002024 0.009242
1020 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 63 162 0.002026 0.009242
1021 METENCEPHALON DEVELOPMENT 42 100 0.002049 0.009328
1022 PEPTIDYL TYROSINE DEPHOSPHORYLATION 42 100 0.002049 0.009328
1023 NEGATIVE REGULATION OF CELL CYCLE PROCESS 80 214 0.002107 0.009585
1024 PROTEIN COMPLEX BIOGENESIS 362 1132 0.002137 0.0097
1025 PROTEIN COMPLEX ASSEMBLY 362 1132 0.002137 0.0097
1026 RESPONSE TO FATTY ACID 36 83 0.002139 0.009702
1027 SPINAL CORD DEVELOPMENT 44 106 0.002146 0.009721
1028 NOSE DEVELOPMENT 10 15 0.002177 0.009814
1029 CELL COMMUNICATION BY ELECTRICAL COUPLING 10 15 0.002177 0.009814
1030 BLASTODERM SEGMENTATION 10 15 0.002177 0.009814
1031 NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 10 15 0.002177 0.009814
1032 VENOUS BLOOD VESSEL DEVELOPMENT 10 15 0.002177 0.009814
1033 MULTICELLULAR ORGANISMAL WATER HOMEOSTASIS 27 58 0.002188 0.009854
NumGOOverlapSizeP ValueAdj. P Value
1 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 278 629 2.366e-18 1.172e-15
2 ENZYME BINDING 649 1737 2.523e-18 1.172e-15
3 KINASE BINDING 266 606 3.824e-17 1.184e-14
4 MACROMOLECULAR COMPLEX BINDING 533 1399 5.746e-17 1.335e-14
5 CALCIUM ION BINDING 296 697 1.488e-16 2.368e-14
6 RECEPTOR BINDING 556 1476 1.529e-16 2.368e-14
7 REGULATORY REGION NUCLEIC ACID BINDING 337 818 2.342e-16 3.109e-14
8 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 463 1199 5.513e-16 6.402e-14
9 CYTOSKELETAL PROTEIN BINDING 335 819 9.708e-16 9.981e-14
10 MOLECULAR FUNCTION REGULATOR 512 1353 1.074e-15 9.981e-14
11 PROTEIN COMPLEX BINDING 373 935 1.936e-15 1.589e-13
12 DOUBLE STRANDED DNA BINDING 315 764 2.052e-15 1.589e-13
13 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 158 328 8.805e-15 6.292e-13
14 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 153 315 9.647e-15 6.402e-13
15 IDENTICAL PROTEIN BINDING 456 1209 8.514e-14 5.273e-12
16 SEQUENCE SPECIFIC DNA BINDING 399 1037 1.252e-13 7.267e-12
17 TRANSMEMBRANE TRANSPORTER ACTIVITY 383 997 5.195e-13 2.839e-11
18 GLYCOSAMINOGLYCAN BINDING 106 205 8.706e-13 4.493e-11
19 RIBONUCLEOTIDE BINDING 656 1860 1.634e-12 7.99e-11
20 GROWTH FACTOR BINDING 72 123 1.729e-12 8.03e-11
21 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 113 226 2.759e-12 1.221e-10
22 PROTEIN HOMODIMERIZATION ACTIVITY 287 722 6.201e-12 2.619e-10
23 PROTEIN DOMAIN SPECIFIC BINDING 253 624 1.054e-11 4.257e-10
24 PROTEIN DIMERIZATION ACTIVITY 425 1149 1.646e-11 6.372e-10
25 ACTIN BINDING 172 393 1.999e-11 7.428e-10
26 PROTEIN KINASE ACTIVITY 257 640 2.372e-11 8.476e-10
27 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 179 417 5.545e-11 1.908e-09
28 CORE PROMOTER PROXIMAL REGION DNA BINDING 161 371 1.907e-10 6.327e-09
29 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 50 81 3.061e-10 9.805e-09
30 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 192 464 4.713e-10 1.459e-08
31 KINASE ACTIVITY 318 842 5.001e-10 1.499e-08
32 SULFUR COMPOUND BINDING 110 234 6.169e-10 1.791e-08
33 ADENYL NUCLEOTIDE BINDING 529 1514 1.483e-09 4.176e-08
34 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 41 64 2.429e-09 6.637e-08
35 HEPARIN BINDING 79 157 3.47e-09 9.21e-08
36 TRANSPORTER ACTIVITY 452 1276 3.571e-09 9.214e-08
37 CELL ADHESION MOLECULE BINDING 90 186 3.682e-09 9.244e-08
38 PROTEIN TYROSINE KINASE ACTIVITY 85 176 1.105e-08 2.702e-07
39 COLLAGEN BINDING 40 65 2.049e-08 4.881e-07
40 CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 237 622 3.546e-08 8.235e-07
41 GATED CHANNEL ACTIVITY 137 325 3.749e-08 8.494e-07
42 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 138 329 4.808e-08 1.064e-06
43 SH3 DOMAIN BINDING 60 116 7.202e-08 1.556e-06
44 INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 204 527 8.1e-08 1.71e-06
45 CATION CHANNEL ACTIVITY 126 298 1.06e-07 2.188e-06
46 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 127 303 1.702e-07 3.437e-06
47 ENZYME REGULATOR ACTIVITY 340 959 3.076e-07 6.08e-06
48 VOLTAGE GATED ION CHANNEL ACTIVITY 86 190 3.532e-07 6.836e-06
49 INTEGRIN BINDING 54 105 4.052e-07 7.683e-06
50 RECEPTOR SIGNALING PROTEIN ACTIVITY 79 172 5.029e-07 9.344e-06
51 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 99 228 5.473e-07 9.97e-06
52 POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 68 143 6.432e-07 1.149e-05
53 ENZYME ACTIVATOR ACTIVITY 181 471 7.53e-07 1.32e-05
54 GROWTH FACTOR ACTIVITY 72 160 3.959e-06 6.81e-05
55 CALMODULIN BINDING 78 179 7.094e-06 0.0001198
56 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 341 992 7.403e-06 0.0001228
57 PROTEIN SERINE THREONINE KINASE ACTIVITY 167 445 9.999e-06 0.000163
58 VOLTAGE GATED CATION CHANNEL ACTIVITY 61 134 1.349e-05 0.0002161
59 TRANSFORMING GROWTH FACTOR BETA BINDING 13 16 1.586e-05 0.0002498
60 HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES 285 820 1.643e-05 0.0002543
61 MONOVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 140 366 1.695e-05 0.0002579
62 TUBULIN BINDING 109 273 1.722e-05 0.0002579
63 VOLTAGE GATED SODIUM CHANNEL ACTIVITY 15 20 1.872e-05 0.000276
64 STEROID HORMONE RECEPTOR ACTIVITY 32 59 2.256e-05 0.0003274
65 PHOSPHORIC ESTER HYDROLASE ACTIVITY 140 368 2.325e-05 0.0003323
66 CHANNEL REGULATOR ACTIVITY 59 131 2.744e-05 0.0003863
67 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 72 168 3.081e-05 0.0004272
68 NUCLEOSIDE DIPHOSPHATASE ACTIVITY 11 13 3.806e-05 0.0005199
69 INSULIN LIKE GROWTH FACTOR BINDING 17 25 4.067e-05 0.0005476
70 MICROTUBULE BINDING 83 201 4.135e-05 0.0005488
71 X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 12 15 4.609e-05 0.0006031
72 CYTOKINE BINDING 44 92 4.842e-05 0.0006176
73 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 209 588 4.853e-05 0.0006176
74 ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 134 356 6.13e-05 0.0007593
75 POTASSIUM CHANNEL ACTIVITY 54 120 6.053e-05 0.0007593
76 PROTEOGLYCAN BINDING 19 30 6.339e-05 0.0007649
77 TRANSCRIPTION FACTOR BINDING 188 524 6.314e-05 0.0007649
78 GLYCOPROTEIN BINDING 47 101 6.458e-05 0.0007692
79 CHROMATIN BINDING 159 435 7.878e-05 0.0009264
80 GUANYL NUCLEOTIDE BINDING 144 390 9.735e-05 0.00113
81 SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 59 136 0.000102 0.00117
82 SEMAPHORIN RECEPTOR BINDING 15 22 0.0001123 0.001272
83 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC 11 14 0.000132 0.001477
84 PDZ DOMAIN BINDING 42 90 0.0001429 0.00158
85 CYCLIC NUCLEOTIDE BINDING 21 36 0.0001455 0.001591
86 ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 111 293 0.0001871 0.002021
87 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 16 25 0.0002038 0.00217
88 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 47 105 0.0002055 0.00217
89 CAMP BINDING 15 23 0.0002386 0.00249
90 VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY 41 89 0.0002412 0.00249
91 BHLH TRANSCRIPTION FACTOR BINDING 17 28 0.0003237 0.003269
92 INTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY 17 28 0.0003237 0.003269
93 ENHANCER BINDING 42 93 0.0003463 0.003459
94 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 11 15 0.0003682 0.003639
95 TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING 25 48 0.0004019 0.00393
96 ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 59 142 0.0004121 0.003988
97 HISTONE DEACETYLASE BINDING 46 105 0.0004325 0.004142
98 CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 54 128 0.0004554 0.004317
99 ION CHANNEL BINDING 48 111 0.0004718 0.004427
100 RNA POLYMERASE II TRANSCRIPTION COACTIVATOR ACTIVITY 20 36 0.0005078 0.00467
101 FRIZZLED BINDING 20 36 0.0005078 0.00467
102 DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 67 167 0.0005665 0.005098
103 GROWTH FACTOR RECEPTOR BINDING 54 129 0.0005709 0.005098
104 SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 89 233 0.000564 0.005098
105 TRANSCRIPTION COREPRESSOR ACTIVITY 85 221 0.0005762 0.005098
106 ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY 19 34 0.0006335 0.005503
107 PROTEIN HETERODIMERIZATION ACTIVITY 164 468 0.0006338 0.005503
108 PHOSPHORIC DIESTER HYDROLASE ACTIVITY 40 90 0.0007024 0.005987
109 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 40 90 0.0007024 0.005987
110 CHEMOREPELLENT ACTIVITY 16 27 0.0007101 0.005997
111 SYMPORTER ACTIVITY 58 142 0.0007642 0.006396
112 LIPID BINDING 222 657 0.0008069 0.006693
113 RECEPTOR AGONIST ACTIVITY 11 16 0.0008774 0.00715
114 LIGAND GATED CALCIUM CHANNEL ACTIVITY 11 16 0.0008774 0.00715
115 PHOSPHATIDYLINOSITOL 3 KINASE BINDING 17 30 0.0009842 0.007951
116 BINDING BRIDGING 68 173 0.0009963 0.007979
117 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 26 53 0.001013 0.008044
118 SMAD BINDING 33 72 0.001047 0.00824
119 G PROTEIN COUPLED RECEPTOR BINDING 96 259 0.001124 0.008778
120 EXTRACELLULAR MATRIX BINDING 25 51 0.001275 0.009873
NumGOOverlapSizeP ValueAdj. P Value
1 NEURON PART 527 1265 1.557e-26 9.094e-24
2 INTRINSIC COMPONENT OF PLASMA MEMBRANE 653 1649 1.112e-25 3.248e-23
3 MEMBRANE REGION 475 1134 1.565e-24 3.047e-22
4 CELL JUNCTION 480 1151 2.691e-24 3.928e-22
5 EXTRACELLULAR MATRIX 218 426 4.426e-24 5.17e-22
6 PROTEINACEOUS EXTRACELLULAR MATRIX 187 356 1.683e-22 1.639e-20
7 NEURON PROJECTION 399 942 9.784e-22 8.163e-20
8 PLASMA MEMBRANE REGION 394 929 1.361e-21 9.933e-20
9 CELL PROJECTION 678 1786 4.437e-21 2.879e-19
10 SYNAPSE 330 754 9.114e-21 5.323e-19
11 SYNAPSE PART 266 610 1.053e-16 5.591e-15
12 SOMATODENDRITIC COMPARTMENT 275 650 3.225e-15 1.569e-13
13 CELL SURFACE 308 757 3.299e-14 1.482e-12
14 CELL CELL JUNCTION 174 383 3.124e-13 1.303e-11
15 EXTRACELLULAR MATRIX COMPONENT 74 125 3.85e-13 1.499e-11
16 INTRACELLULAR VESICLE 467 1259 9.055e-13 3.282e-11
17 CELL PROJECTION PART 365 946 9.553e-13 3.282e-11
18 DENDRITE 195 451 3.501e-12 1.136e-10
19 CELL BODY 207 494 2.574e-11 7.911e-10
20 PLASMA MEMBRANE PROTEIN COMPLEX 211 510 6.638e-11 1.938e-09
21 CYTOSKELETON 677 1967 1.193e-10 3.318e-09
22 SARCOLEMMA 69 125 1.944e-10 5.161e-09
23 POSTSYNAPSE 163 378 2.635e-10 6.433e-09
24 AXON 177 418 2.644e-10 6.433e-09
25 MEMBRANE MICRODOMAIN 130 288 5.087e-10 1.188e-08
26 ACTIN CYTOSKELETON 183 444 1.732e-09 3.89e-08
27 APICAL PART OF CELL 154 361 2.04e-09 4.413e-08
28 PRESYNAPSE 126 283 2.663e-09 5.553e-08
29 EXTRACELLULAR SPACE 484 1376 2.863e-09 5.765e-08
30 EXCITATORY SYNAPSE 94 197 4.131e-09 7.884e-08
31 RECEPTOR COMPLEX 141 327 4.185e-09 7.884e-08
32 APICAL PLASMA MEMBRANE 128 292 6.435e-09 1.174e-07
33 CONTRACTILE FIBER 98 211 1.128e-08 1.995e-07
34 ANCHORING JUNCTION 195 489 1.161e-08 1.995e-07
35 SIDE OF MEMBRANE 174 428 1.418e-08 2.365e-07
36 BASEMENT MEMBRANE 52 93 1.805e-08 2.927e-07
37 CYTOPLASMIC VESICLE PART 231 601 2.283e-08 3.604e-07
38 AXON PART 99 219 5.17e-08 7.946e-07
39 BASOLATERAL PLASMA MEMBRANE 96 211 5.577e-08 8.351e-07
40 I BAND 62 121 6.901e-08 1.007e-06
41 T TUBULE 30 45 9.017e-08 1.284e-06
42 PERINUCLEAR REGION OF CYTOPLASM 241 642 1.155e-07 1.607e-06
43 CELL SUBSTRATE JUNCTION 159 398 2.221e-07 2.947e-06
44 PLASMA MEMBRANE RAFT 47 86 2.19e-07 2.947e-06
45 GOLGI APPARATUS 491 1445 3.349e-07 4.346e-06
46 SECRETORY VESICLE 179 461 3.916e-07 4.972e-06
47 CYTOPLASMIC SIDE OF MEMBRANE 78 170 6.235e-07 7.747e-06
48 CELL CELL CONTACT ZONE 37 64 6.538e-07 7.955e-06
49 VESICLE MEMBRANE 194 512 9.459e-07 1.127e-05
50 NEURONAL POSTSYNAPTIC DENSITY 32 53 9.765e-07 1.141e-05
51 CATION CHANNEL COMPLEX 76 167 1.276e-06 1.461e-05
52 SYNAPTIC MEMBRANE 109 261 1.518e-06 1.704e-05
53 CELL LEADING EDGE 139 350 1.832e-06 2.018e-05
54 TRANSPORTER COMPLEX 129 321 2.067e-06 2.236e-05
55 EXOCYTIC VESICLE 66 142 2.542e-06 2.666e-05
56 MEMBRANE PROTEIN COMPLEX 353 1020 2.556e-06 2.666e-05
57 EXTRINSIC COMPONENT OF MEMBRANE 105 252 2.653e-06 2.718e-05
58 PLATELET ALPHA GRANULE 40 75 3.891e-06 3.918e-05
59 CELL PROJECTION MEMBRANE 120 298 4.107e-06 4.065e-05
60 INTERCALATED DISC 30 51 4.54e-06 4.419e-05
61 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 63 136 4.877e-06 4.669e-05
62 NEURON PROJECTION TERMINUS 60 129 6.923e-06 6.521e-05
63 MYELIN SHEATH 74 168 7.565e-06 7.013e-05
64 ACTOMYOSIN 34 62 9.169e-06 8.367e-05
65 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 48 98 1.005e-05 9.027e-05
66 VOLTAGE GATED SODIUM CHANNEL COMPLEX 12 14 1.244e-05 0.00011
67 CELL CORTEX 97 238 1.854e-05 0.0001616
68 POTASSIUM CHANNEL COMPLEX 44 90 2.455e-05 0.0002109
69 COMPLEX OF COLLAGEN TRIMERS 16 23 4.492e-05 0.0003802
70 POSTSYNAPTIC MEMBRANE 84 205 5.184e-05 0.0004325
71 APICAL JUNCTION COMPLEX 57 128 5.516e-05 0.0004537
72 ENDOPLASMIC RETICULUM LUMEN 82 201 7.57e-05 0.000614
73 CYTOSKELETAL PART 467 1436 0.0001017 0.000814
74 CORTICAL CYTOSKELETON 39 81 0.000106 0.0008296
75 PLATELET ALPHA GRANULE LUMEN 29 55 0.0001065 0.0008296
76 MICROTUBULE CYTOSKELETON 355 1068 0.0001141 0.0008765
77 ENDOPLASMIC RETICULUM 525 1631 0.0001165 0.000884
78 INTERSTITIAL MATRIX 11 14 0.000132 0.0009883
79 SITE OF POLARIZED GROWTH 63 149 0.0001492 0.001103
80 MIDBODY 57 132 0.000154 0.001124
81 NEURON SPINE 53 121 0.0001665 0.0012
82 EXTERNAL SIDE OF PLASMA MEMBRANE 93 238 0.0001722 0.001226
83 COLLAGEN TRIMER 41 88 0.0001782 0.001254
84 CELL CORTEX PART 52 119 0.0002052 0.001426
85 ACTIN FILAMENT 34 70 0.0002324 0.001597
86 BASAL LAMINA 14 21 0.0002754 0.00187
87 SARCOPLASM 33 68 0.0002914 0.001956
88 GOLGI APPARATUS PART 298 893 0.000296 0.001964
89 CYTOPLASMIC REGION 108 287 0.0003038 0.001994
90 SECRETORY GRANULE 129 352 0.0003122 0.002026
91 SODIUM CHANNEL COMPLEX 12 17 0.0003453 0.002216
92 CORTICAL ACTIN CYTOSKELETON 29 58 0.0003535 0.00222
93 MAIN AXON 29 58 0.0003535 0.00222
94 FILOPODIUM 42 94 0.0004571 0.002761
95 MICROTUBULE 145 405 0.0004558 0.002761
96 GOLGI LUMEN 42 94 0.0004571 0.002761
97 TERMINAL BOUTON 31 64 0.0004586 0.002761
98 BASAL PART OF CELL 26 51 0.0004788 0.002854
99 COATED PIT 32 67 0.0005122 0.003022
100 RUFFLE 63 156 0.0006641 0.00384
101 FILAMENTOUS ACTIN 13 20 0.0006619 0.00384
102 PRESYNAPTIC MEMBRANE 27 55 0.0008052 0.00461
103 ACTIN BASED CELL PROJECTION 71 181 0.0008355 0.004737
104 BANDED COLLAGEN FIBRIL 9 12 0.001027 0.005765
105 SECRETORY GRANULE MEMBRANE 35 78 0.001197 0.006658
106 VACUOLE 379 1180 0.001224 0.006743
107 GLYCOPROTEIN COMPLEX 13 21 0.00129 0.00704
108 NEUROMUSCULAR JUNCTION 26 54 0.001435 0.007759
109 ACTIN FILAMENT BUNDLE 27 57 0.001592 0.008529
110 LEADING EDGE MEMBRANE 54 134 0.001635 0.008681
111 ENDOCYTIC VESICLE 94 256 0.00176 0.009258
112 LYSOSOMAL LUMEN 38 88 0.001804 0.009406

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04010_MAPK_signaling_pathway 113 387 0.3456 1
2 hsa04510_Focal_adhesion 104 387 0.7361 1
3 hsa04020_Calcium_signaling_pathway 85 387 0.9979 1
4 hsa04810_Regulation_of_actin_cytoskeleton 79 387 0.9998 1
5 hsa00010_Glycolysis_._Gluconeogenesis 24 387 1 1
6 hsa00020_Citrate_cycle_.TCA_cycle. 7 387 1 1
7 hsa00030_Pentose_phosphate_pathway 12 387 1 1
8 hsa00040_Pentose_and_glucuronate_interconversions 3 387 1 1
9 hsa00051_Fructose_and_mannose_metabolism 17 387 1 1
10 hsa00052_Galactose_metabolism 8 387 1 1
11 hsa00053_Ascorbate_and_aldarate_metabolism 2 387 1 1
12 hsa00061_Fatty_acid_biosynthesis 3 387 1 1
13 hsa00071_Fatty_acid_metabolism 12 387 1 1
14 hsa00072_Synthesis_and_degradation_of_ketone_bodies 5 387 1 1
15 hsa00100_Steroid_biosynthesis 6 387 1 1
16 hsa00120_Primary_bile_acid_biosynthesis 6 387 1 1
17 hsa00140_Steroid_hormone_biosynthesis 9 387 1 1
18 hsa00190_Oxidative_phosphorylation 26 387 1 1
19 hsa00230_Purine_metabolism 58 387 1 1
20 hsa00240_Pyrimidine_metabolism 23 387 1 1
21 hsa00250_Alanine._aspartate_and_glutamate_metabolism 13 387 1 1
22 hsa00260_Glycine._serine_and_threonine_metabolism 12 387 1 1
23 hsa00270_Cysteine_and_methionine_metabolism 11 387 1 1
24 hsa00280_Valine._leucine_and_isoleucine_degradation 9 387 1 1
25 hsa00310_Lysine_degradation 14 387 1 1
26 hsa00330_Arginine_and_proline_metabolism 18 387 1 1
27 hsa00340_Histidine_metabolism 9 387 1 1
28 hsa00350_Tyrosine_metabolism 13 387 1 1
29 hsa00360_Phenylalanine_metabolism 6 387 1 1
30 hsa00380_Tryptophan_metabolism 13 387 1 1
31 hsa00410_beta.Alanine_metabolism 7 387 1 1
32 hsa00430_Taurine_and_hypotaurine_metabolism 3 387 1 1
33 hsa00450_Selenocompound_metabolism 8 387 1 1
34 hsa00460_Cyanoamino_acid_metabolism 2 387 1 1
35 hsa00471_D.Glutamine_and_D.glutamate_metabolism 3 387 1 1
36 hsa00480_Glutathione_metabolism 12 387 1 1
37 hsa00500_Starch_and_sucrose_metabolism 8 387 1 1
38 hsa00510_N.Glycan_biosynthesis 13 387 1 1
39 hsa00511_Other_glycan_degradation 3 387 1 1
40 hsa00512_Mucin_type_O.Glycan_biosynthesis 15 387 1 1
41 hsa00514_Other_types_of_O.glycan_biosynthesis 6 387 1 1
42 hsa00520_Amino_sugar_and_nucleotide_sugar_metabolism 15 387 1 1
43 hsa00531_Glycosaminoglycan_degradation 4 387 1 1
44 hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate 9 387 1 1
45 hsa00533_Glycosaminoglycan_biosynthesis_._keratan_sulfate 6 387 1 1
46 hsa00534_Glycosaminoglycan_biosynthesis_._heparan_sulfate 9 387 1 1
47 hsa00561_Glycerolipid_metabolism 15 387 1 1
48 hsa00562_Inositol_phosphate_metabolism 19 387 1 1
49 hsa00563_Glycosylphosphatidylinositol.GPI..anchor_biosynthesis 6 387 1 1
50 hsa00564_Glycerophospholipid_metabolism 24 387 1 1
51 hsa00565_Ether_lipid_metabolism 10 387 1 1
52 hsa00590_Arachidonic_acid_metabolism 15 387 1 1
53 hsa00591_Linoleic_acid_metabolism 9 387 1 1
54 hsa00592_alpha.Linolenic_acid_metabolism 6 387 1 1
55 hsa00600_Sphingolipid_metabolism 11 387 1 1
56 hsa00601_Glycosphingolipid_biosynthesis_._lacto_and_neolacto_series 12 387 1 1
57 hsa00603_Glycosphingolipid_biosynthesis_._globo_series 4 387 1 1
58 hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series 7 387 1 1
59 hsa00620_Pyruvate_metabolism 11 387 1 1
60 hsa00630_Glyoxylate_and_dicarboxylate_metabolism 4 387 1 1
61 hsa00640_Propanoate_metabolism 8 387 1 1
62 hsa00650_Butanoate_metabolism 12 387 1 1
63 hsa00670_One_carbon_pool_by_folate 10 387 1 1
64 hsa00740_Riboflavin_metabolism 5 387 1 1
65 hsa00750_Vitamin_B6_metabolism 5 387 1 1
66 hsa00760_Nicotinate_and_nicotinamide_metabolism 9 387 1 1
67 hsa00770_Pantothenate_and_CoA_biosynthesis 7 387 1 1
68 hsa00780_Biotin_metabolism 2 387 1 1
69 hsa00790_Folate_biosynthesis 3 387 1 1
70 hsa00830_Retinol_metabolism 13 387 1 1
71 hsa00860_Porphyrin_and_chlorophyll_metabolism 6 387 1 1
72 hsa00900_Terpenoid_backbone_biosynthesis 5 387 1 1
73 hsa00910_Nitrogen_metabolism 12 387 1 1
74 hsa00920_Sulfur_metabolism 2 387 1 1
75 hsa00970_Aminoacyl.tRNA_biosynthesis 13 387 1 1
76 hsa00980_Metabolism_of_xenobiotics_by_cytochrome_P450 12 387 1 1
77 hsa00982_Drug_metabolism_._cytochrome_P450 16 387 1 1
78 hsa00983_Drug_metabolism_._other_enzymes 9 387 1 1
79 hsa01040_Biosynthesis_of_unsaturated_fatty_acids 5 387 1 1
80 hsa02010_ABC_transporters 16 387 1 1
81 hsa03008_Ribosome_biogenesis_in_eukaryotes 11 387 1 1
82 hsa03010_Ribosome 12 387 1 1
83 hsa03013_RNA_transport 29 387 1 1
84 hsa03015_mRNA_surveillance_pathway 18 387 1 1
85 hsa03018_RNA_degradation 14 387 1 1
86 hsa03020_RNA_polymerase 4 387 1 1
87 hsa03022_Basal_transcription_factors 7 387 1 1
88 hsa03030_DNA_replication 13 387 1 1
89 hsa03040_Spliceosome 15 387 1 1
90 hsa03050_Proteasome 14 387 1 1
91 hsa03060_Protein_export 9 387 1 1
92 hsa03320_PPAR_signaling_pathway 26 387 1 1
93 hsa03410_Base_excision_repair 6 387 1 1
94 hsa03420_Nucleotide_excision_repair 8 387 1 1
95 hsa03430_Mismatch_repair 5 387 1 1
96 hsa03440_Homologous_recombination 7 387 1 1
97 hsa04012_ErbB_signaling_pathway 43 387 1 1
98 hsa04062_Chemokine_signaling_pathway 67 387 1 1
99 hsa04070_Phosphatidylinositol_signaling_system 32 387 1 1
100 hsa04110_Cell_cycle 58 387 1 1
101 hsa04114_Oocyte_meiosis 44 387 1 1
102 hsa04115_p53_signaling_pathway 33 387 1 1
103 hsa04120_Ubiquitin_mediated_proteolysis 29 387 1 1
104 hsa04130_SNARE_interactions_in_vesicular_transport 14 387 1 1
105 hsa04140_Regulation_of_autophagy 8 387 1 1
106 hsa04141_Protein_processing_in_endoplasmic_reticulum 58 387 1 1
107 hsa04142_Lysosome 39 387 1 1
108 hsa04144_Endocytosis 65 387 1 1
109 hsa04145_Phagosome 46 387 1 1
110 hsa04146_Peroxisome 18 387 1 1
111 hsa04150_mTOR_signaling_pathway 27 387 1 1
112 hsa04210_Apoptosis 39 387 1 1
113 hsa04260_Cardiac_muscle_contraction 25 387 1 1
114 hsa04270_Vascular_smooth_muscle_contraction 57 387 1 1
115 hsa04310_Wnt_signaling_pathway 64 387 1 1
116 hsa04320_Dorso.ventral_axis_formation 14 387 1 1
117 hsa04330_Notch_signaling_pathway 18 387 1 1
118 hsa04340_Hedgehog_signaling_pathway 29 387 1 1
119 hsa04350_TGF.beta_signaling_pathway 45 387 1 1
120 hsa04360_Axon_guidance 66 387 1 1
121 hsa04370_VEGF_signaling_pathway 26 387 1 1
122 hsa04380_Osteoclast_differentiation 53 387 1 1
123 hsa04512_ECM.receptor_interaction 48 387 1 1
124 hsa04514_Cell_adhesion_molecules_.CAMs. 69 387 1 1
125 hsa04520_Adherens_junction 30 387 1 1
126 hsa04530_Tight_junction 51 387 1 1
127 hsa04540_Gap_junction 39 387 1 1
128 hsa04610_Complement_and_coagulation_cascades 30 387 1 1
129 hsa04612_Antigen_processing_and_presentation 21 387 1 1
130 hsa04614_Renin.angiotensin_system 10 387 1 1
131 hsa04620_Toll.like_receptor_signaling_pathway 32 387 1 1
132 hsa04621_NOD.like_receptor_signaling_pathway 14 387 1 1
133 hsa04622_RIG.I.like_receptor_signaling_pathway 14 387 1 1
134 hsa04623_Cytosolic_DNA.sensing_pathway 6 387 1 1
135 hsa04630_Jak.STAT_signaling_pathway 55 387 1 1
136 hsa04640_Hematopoietic_cell_lineage 36 387 1 1
137 hsa04650_Natural_killer_cell_mediated_cytotoxicity 46 387 1 1
138 hsa04660_T_cell_receptor_signaling_pathway 35 387 1 1
139 hsa04662_B_cell_receptor_signaling_pathway 30 387 1 1
140 hsa04664_Fc_epsilon_RI_signaling_pathway 32 387 1 1
141 hsa04666_Fc_gamma_R.mediated_phagocytosis 39 387 1 1
142 hsa04670_Leukocyte_transendothelial_migration 46 387 1 1
143 hsa04672_Intestinal_immune_network_for_IgA_production 14 387 1 1
144 hsa04710_Circadian_rhythm_._mammal 11 387 1 1
145 hsa04720_Long.term_potentiation 32 387 1 1
146 hsa04722_Neurotrophin_signaling_pathway 52 387 1 1
147 hsa04730_Long.term_depression 32 387 1 1
148 hsa04740_Olfactory_transduction 14 388 1 1
149 hsa04742_Taste_transduction 9 387 1 1
150 hsa04744_Phototransduction 6 387 1 1
151 hsa04910_Insulin_signaling_pathway 57 387 1 1
152 hsa04912_GnRH_signaling_pathway 40 387 1 1
153 hsa04914_Progesterone.mediated_oocyte_maturation 37 387 1 1
154 hsa04916_Melanogenesis 44 387 1 1
155 hsa04920_Adipocytokine_signaling_pathway 27 387 1 1
156 hsa04960_Aldosterone.regulated_sodium_reabsorption 24 387 1 1
157 hsa04962_Vasopressin.regulated_water_reabsorption 12 387 1 1
158 hsa04964_Proximal_tubule_bicarbonate_reclamation 15 387 1 1
159 hsa04966_Collecting_duct_acid_secretion 8 387 1 1
160 hsa04970_Salivary_secretion 33 387 1 1
161 hsa04971_Gastric_acid_secretion 32 387 1 1
162 hsa04972_Pancreatic_secretion 34 387 1 1
163 hsa04973_Carbohydrate_digestion_and_absorption 19 387 1 1
164 hsa04974_Protein_digestion_and_absorption 41 387 1 1
165 hsa04975_Fat_digestion_and_absorption 10 387 1 1
166 hsa04976_Bile_secretion 26 387 1 1
167 hsa04977_Vitamin_digestion_and_absorption 10 387 1 1

Quest ID: dd434097eb0005c29fdf507370f4b6c0